Stormy clouds in seventh heaven:A study on anxiety and depression around childbirth by Meijer, Judith Linda
  
 University of Groningen
Stormy clouds in seventh heaven
Meijer, Judith Linda
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Meijer, J. L. (2015). Stormy clouds in seventh heaven: A study on anxiety and depression around childbirth.
[Groningen]: University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Stormy clouds in seventh heaven
 
A study on anxiety and depression around 
childbirth
Judith Aris-Meijer
 Stormy clouds in seventh heaven. A study on anxiety and depression around childbirth.
Thesis, University of Groningen, the Netherlands
ISBN (printed)  978-90-367-8304-0
ISBN (e-book)  978-90-367-8303-3
Author     J.L. Aris-Meijer
Cover design & printing All covers and invitations were designed and screen printed by 
   hand, by Helemaalkim (www.helemaalkim.com), in Vera   
   Groningen 
Lay-out   J.L. Aris-Meijer, Helemaalkim
Printed by  Ridderprint BV, Ridderkerk
Copyright © J.L. Aris-Meijer, Groningen 2015
All rights reserved. No part of this thesis may be reproduced or transmitted in any form by 
any means, without permission of the copyright owner.
The studies presented in this thesis were supported by ZonMw, the Netherlands Organization 
for Health Research and Development (grant number 120520013)














Stormy clouds in seventh heaven 
 










ter verkrijging van de graad van doctor aan de 
Rijksuniversiteit Groningen 
op gezag van de 
rector magnificus prof. dr. E. Sterken 
en volgens besluit van het College voor Promoties. 
 
De openbare verdediging zal plaatsvinden op  
 









Judith Linda Meijer  




Prof. dr. C.L.H. Bockting




Prof. dr. S.A. Scherjon 
Prof. dr. A. van Straten





1. Introduction page 09
2. Associations of life events during pregnancy with longitudinal change in 
symptoms of antenatal anxiety and depression (Meijer et al., Midwifery, 
2014)
page 19
3. What if pregnancy is not seventh heaven? The influence of specific life 
events during pregnancy and delivery on the transition of antenatal into 
postpartum anxiety and depression. (Meijer et al., submitted)
page 37
4. Predictive accuracy of Edinburgh Postnatal Depression Scale (EPDS) 
assessment during pregnancy for the risk of developing postpartum 
depressive symptoms: a prospective cohort study (Meijer et al., BJOG, 
2014)
page 51
5. Predictive accuracy of State and Trait Anxiety Inventory (STAI) 
assessment during pregnancy for the risk of developing postpartum 
symptoms of anxiety: a prospective cohort study (Meijer et al., submitted)
page 67
6. Design of the PRegnancy Outcomes after a Maternity Intervention for 
Stressful EmotionS (PROMISES) trial (based on Meijer et al., Trials 2011, 
and Burger et al, Perinatal Programming of Neurodevelopment, 2014)
page 85
7. General Discussion page 103
Summary in English page 121
Nederlandse samenvatting page 127
Acknowledgements page 133
Curriculum Vitae page 139
List of publications page 143






About anxiety and depression
Women are at increased risk for the experience of symptoms of anxiety or depression 
during their reproductive years1. Incidence rates are highest amongst women between 18 
and 45 years of age2-6. During and outside pregnancy alike, approximately 10-15% of all 
women experience symptoms of anxiety or depression7-10. It has been estimated that in 2030, 
depression will be in the top 10 of most prevalent diseases11. 
In general, symptoms of anxiety and depression may include negative thoughts, loss of 
energy, sleep disturbances, loss of interest or pleasure, and in some cases suicidal ideations 
and plans 12. Antenatal (i.e. during pregnancy) or postpartum (i.e. postpartum after delivery) 
anxiety and depression usually manifest with these same symptoms12. Box 1 contains the 
Postpartum Onset specifier for Depressive Disorders, according to the DSM-IV. Risk factors 
for antenatal symptoms are not necessarily related to pregnancy, though it is known that 
women who suffered previous pregnancy or infant loss often experience anxiety during the 
subsequent pregnancy13,14. 
Consequences of anxiety or depression during pregnancy or in the  postpartum 
period
Symptoms of anxiety and depression during pregnancy have been associated with several 
adverse outcomes for mother and child. For example, women tend to seek less prenatal care, 
continue their use of alcohol and tobacco, and they are at increased risk for postpartum 
anxiety and depression15-18. Additionally, low birth weight, preterm delivery, insecure mother-
child attachment and emotional and behavioral problems in the child have been found19,20. 
One of the hypotheses on the mechanism behind this latter observation is that cortisol levels 
are increased as a result of maternal stress, which influences the development of the fetal 
brain as cortisol passes the placenta. 
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BOX 1 SPECIFIER WITH POSTPARTUM ONSET – DSM-IV
 
“The specifier With Postpartum Onset can be applied to the current (or, if the full criteria 
are not currently met for a Major Depressive, Manic, or Mixed Episode, to the most recent) 
Major Depressive, Manic, or Mixed Episode of Major Depressive Disorder, Bipolar I Disorder, 
or Bipolar II Disorder or to Brief Psychotic Disorder (p.329) if onset is within 4 weeks after 
childbirth. The symptoms of the postpartum-onset Major Depressive, Manic, or Mixed 
Episode do not differ from the symptoms in nonpostpartum mood episodes. Symptoms that 
are common in postpartum-onset episodes, though not specific to postpartum onset, include 
fluctuations in mood, mood lability, and preoccupation with infant well-being, the intensity 
of which may range from overconcern to frank delusions. The presence of severe ruminations 
or delusional thoughts about the infant is associated with a significantly increased risk of 
harm to the infant. 
Postpartum-onset mood episodes can present either with or without psychotic 
features. Infanticide is most often associated with postpartum psychotic episodes that are 
characterized by command hallucinations to kill the infant or delusions that the infant is 
possessed, but it can also occur in severe postpartum mood episodes without such specific 
delusions or hallucinations. Postpartum mood (Major Depressive, Manic, or Mixed) episodes 
with psychotic features appear to occur in from 1 in 500 to 1 in 1,000 deliveries and may 
be more common in primiparous women. The risk of postpartum episodes with psychotic 
features is particularly increased for women with prior postpartum mood episodes but is 
also elevated for those with a prior history of a Mood Disorder (especially Bipolar I Disorder). 
Once a woman has had a postpartum episode with psychotic features, the risk of recurrence 
with each subsequent delivery is between 30% and 50%. There is also some evidence of 
increased risk of postpartum psychotic mood episodes among women without a history of 
Mood Disorders with a  family history of Bipolar Disorders. Postpartum episodes must be 
differentiated from delirium occurring in the postpartum period, which is distinguished by a 
decreased level of awareness or attention. 
Women with postpartum Major Depressive Episodes often have severe anxiety and 
even Panic Attacks. Maternal attitudes toward the infant are highly variable but can include 
disinterest, fearfulness of being alone with the infant, or overintrusiveness that inhibits 
adequate infant rest. It is important to distinguish postpartum mood episodes from the “baby 
blues”, which affect up to 70% of women during the 10 days postpartum, are transient, and 
do not impair functioning. Prospective studies have demonstrated that mood and anxiety 
symptoms during pregnancy, as well as the “baby blues”, increase the risk for a postpartum 
Major Depressive Episode. A past personal history of nonpostpartum Mood Disorder and a 
family history of Mood Disorders also increase the risk for the development of a postpartum 
Mood Disorder. The risk factors, recurrence rates, and symptoms of postpartum-onset Mood 
Episodes are similar to those of nonpostpartum Mood Episodes. However, the postpartum 
period is unique with respect to the degree of neuroendocrine alterations and psychosocial 
adjustments, the potential impact of breast-feeding on treatment planning, and the long-
term implications of a history of postpartum Mood Disorder on subsequent family planning.”
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Risk factors associated with anxiety or depression during pregnancy or in the 
postpartum period
Well known risk factors for the onset and persistence of anxiety and depression outside 
pregnancy are the experience of these symptoms earlier in life, a family history of mental 
health problems, the experience of traumatic events during childhood, recent major life 
events, low social support, and specific personality traits such as high neuroticism and low 
extraversion21-26. Additionally, personality traits and childhood trauma have been found to 
moderate the associations between life events and psychopathology21,26,27. 
These risk factors also hold for antenatal and postpartum anxiety and depression18,28. 
Additionally, a few large population-based cohort studies (n>5,000) found that experiencing 
obstetric events during pregnancy or events that were related to the condition of the newborn 
(i.e. low birth weight, preterm delivery, congenital malformations, admission to the hospital) 
increased the risk of symptoms of depression in the postpartum period29,30. In total however, 
the growing body of literature on the associations between events related to the pregnancy, 
delivery or newborn and postpartum symptoms of anxiety and depression is inconclusive31-37. 
Screening guidelines
International guidelines recommend screening for perinatal anxiety and depression 
during the first contact between the woman and the midwife or gynaecologist, and as early 
postpartum as possible38,39. The American College of Obstetricians and Gynecologists (ACOG) 
states that women should at least once during the perinatal period be screened, although 
definitive evidence of benefit is absent. Additionally, they advise to monitor women with 
current symptomatology or with risk factors for symptomatology closely. The National 
Institute for Health and Clinical Excellence (NICE) guidelines recommends the use of two 
questions based on the key symptoms of depression, i.e. low mood and anhedonia, and 
to ask for specific events in the past period. They recently added the recommendation to 
use a similar screening tool for anxiety, and a recommendation for further questionnaires 
or referral to the general practitioner or a psychiatrist in case the first two questions were 
answered positively. As antenatal anxiety or depression might develop into a clinical disorder 
when untreated28,40, this seems a valuable addition. 
Dutch guidelines for midwives (Koninklijke Nederlandse Organisatie van Verloskundigen, 
KNOV) include a specific supplement on depression, since 200841. They do not recommend 
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specific screening for current symptomatology, but to ask questions about personal and 
family history of mental disorders during the first consult, and to be continuously alert on 
symptoms of depression. 
Treatment options
The Dutch multidisciplinary guideline for mental healthcare42 recommends to take 
hormonal changes into account when treating depression, and to educate women on the 
(continuation of) pharmacological treatment during pregnancy. The NICE has developed 
a specific multidisciplinary guideline for treatment of pregnant women with symptoms of 
depression38, in which pharmacological treatment, non-pharmacological treatment or a 
combination of both is recommended. During pregnancy and the breastfeeding period, 
women generally prefer non-pharmacological treatment43, as consequences of maternal 
antidepressant medication use for treating anxiety or depressive disorders are still unclear 
for the unborn child44. Several psychological therapies are used for treating anxiety and 
depression, such as interpersonal therapy, psychoanalysis, EMDR and cognitive behavioral 
therapy (CBT). The latter is known to be a widely used and the most studied effective therapy 
in treating anxiety and depression45,46.
Overall aims of this thesis 
The general objective of the current thesis was to unravel part of the etiology of developing 
symptoms of depression and anxiety in the antenatal period, and the transition of anxiety 
and depression from the antenatal into the postpartum period. This was accomplished by 
taking associations with specific life events into account, in order to better understand the 
development of these symptoms, and to provide evidence for future guidelines on screening. 
This thesis focuses on risk factors and screening options in order to be able to prevent 
symptoms of anxiety or depression and disorders in the future. The prospective, population-
based Pregnancy, Anxiety and Depression (PAD) cohort study has been designed to answer 
these questions amongst others. The final chapter before the general discussion presents the 
design of a trial including a psychological intervention in pregnant and postpartum women, 




About the PAD and PROMISES study 
The PAD study and the PROMISES study started in 2009. We cooperated with over 100 
primary obstetric care centers and seven hospitals in the Netherlands to invite women in their 
first trimester to participate in the PAD study. In total 7,275 pregnant women were screened 
for symptoms of anxiety and depression. We sent follow-up questionnaires during the second 
and the third trimester and at six weeks, three months and six months postpartum. We 
gathered midwives reports for information about the pregnancy and delivery.  
Women who scored above certain cut-off points for anxiety or depression at baseline 
in the PAD study were invited to participate in the PROMISES study. This is a randomized 
controlled trial, with which we wanted to gain insight in the mechanism behind the apparent 
associations found in women with elevated levels of anxiety or depression during pregnancy 
and a less favorable health of their children, e.g. through fetal programming, a concept 
introduced originally in studies on cardiovascular disease47.  
These women received follow-up questionnaires at the same measurement waves as in 
the PAD study, and additionally at 12 and 18 months postpartum. Their children are currently 
being tested at 18 months on development and behavior. In 2014, the target of including 300 




Overall outline of the thesis
Chapter 2 discusses the associations between change in antenatal anxiety and depression 
levels with several categories of life events during pregnancy and personality traits. A 
distinction is made between general life events and pregnancy related events.
Chapter 3 studies change in anxiety and depression level from early pregnancy to half a year 
postpartum, by assessing the influence of life events during pregnancy. A distinction is made 
between general life events and pregnancy related events, similar to chapter 2. Additionally, 
the difference of these associations between women with and without prevalent antenatal 
symptoms is assessed, and exploratory analyses with events during delivery or related to the 
newborn are discussed.
Chapter 4 discusses whether a commonly used tool in identification and screening of 
antenatal and postpartum anxiety is accurate in predicting individual risk based on antenatal 
levels. 
Chapter 5 demonstrates the predictive accuracy of a tool commonly used in the identification 
and screening of antenatal and postpartum depression, and explores whether this tool can be 
optimized by decreasing the number of questions or adding risk factors.
Chapter 6 presents the design of the ongoing randomized controlled trial.
Finally, the results of the analyses and the practical implications are integrated in the general 
discussion, chapter 7. Here, the Wilson and Jungner criteria for screening are applied in order 
to formulate a recommendation on screening and treatment of antenatal and postpartum 
anxiety and depression. 
chapter 
1
1. Marcus SM, Barry KL, Flynn HA, Tandon R, Greden 
JF. Treatment guidelines for depression in pregnancy. 
Int J Gynaecol Obstet. 2001 Jan;72(1):61-700
2. Kessler RC, McGonagle KA, Swartz M, Blazer DG, 
Nelson CB. Sex and depression in the National 
Comorbidity Survey. I: Lifetime prevalence, 
chronicity and recurrence. J Affect Disord. 1993 Oct-
Nov;29(2-3):85-96.
3. Murray L, Fiori-Cowley A, Hooper R, Cooper P. The 
impact of postnatal depression and associated 
adversity on early mother-infant interactions and 
later infant outcome. Child Dev 1996;67:2512-26.
4. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, 
Gartlehner G, Swinson T. Perinatal depression: a 
systematic review of prevalence and incidence. 
Obstet Gynecol. 2005 Nov;106(5 Pt 1):1071-83.
5. Patten SB, Williams JV, Lavorato DH, Bulloch AG, 
MacQueen G. Depressive episode characteristics 
and subsequent recurrence risk. J Affect Disord. 
2012 Nov;140(3):277-84
6. Stewart DE. Clinical practice. Depression during 
pregnancy. N Engl J Med. 2011 Oct 27;365(17):1605-
11.
7. Marcus SM, Flynn HA, Blow FC, Barry KL: 
Depressive symptoms among pregnant women 
screened in obstetrics settings. J Womens Health 
(Larchmt) 2003, 12:373-380.
8. Bennett HA, Einarson A, Taddio A, Koren G, Einarson 
TR: Prevalence of depression during pregnancy: 
systematic review. Obstet Gynecol 2004, 103:698-
709.
9. Gaynes BN, Gavin N, Meltzer-Brody S, Lohr 
KN, Swinson T, Gartlehner G, Brody S, Miller 
WC: Perinatal depression: prevalence, screening 
accuracy, and screening outcomes. Evid Rep 
Technol Assess (Summ) 2005, (119):1-8.
10. Vesga-López O, Blanco C, Keyes K, Olfson M, Grant 
BF, Hasin DS. Psychiatric disorders in pregnant and 
postpartum women in the United States. Arch Gen 
Psychiatry. 2008 Jul;65(7):805-15.
11. Mathers CD, Loncar D. Projections of global 
mortality and burden of disease from 2002 to 2030. 
PLoS Med 2006;3:e442.
12. American Psychological Association. Diagnostic 
and Statistical Manual of Mental Disorders: DSM-
IV-TR, 4th edn, text revision. Washington, DC: 
American Psychological Association, 2000.
13. Blackmore ER, Côté-Arsenault D, Tang W, Glover V, 
Evans J, Golding J, O’Connor TG. Previous prenatal 
loss as a predictor of perinatal depression and 
anxiety. Br J Psychiatry. 2011 May;198(5):373-8. 
14. McCarthy F, Moss-Morris R, Khashan A, North R, 
Baker P, Dekker G, Poston L, McCowan L, Walker 
J, Kenny L, O’Donoghue K. Previous pregnancy loss 
has an adverse impact on distress and behaviour 
in subsequent pregnancy. BJOG. 2015 Jan 6. doi: 
10.1111/1471-0528.13233
15. Andres RL, Day MC: Perinatal complications 
associated with maternal tobacco use. Semin 
Neonatol 2000, 5:231-41. 
16. Stewart DE: Perinatal depression. Gen Hosp 
Psychiatry 2006, 28:1-2. 
17. O’Keane V, Marsh MS: Depression during 
pregnancy. BMJ 2007, 334:1003-1005.
18. Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, 
Davis MM. Risk factors for depressive symptoms 
during pregnancy: a systematic review. Am J Obstet 
Gynecol 2010 Jan;202(1):5-14.
19. O’Connor TG, Heron J, Glover V, Alspac Study 
Team. Antenatal anxiety predicts child behavioral/
emotional problems independently of postnatal 
depression. J Am Acad Child Adolesc Psychiatry 
2002 Dec;41(12):1470-1477.
20. Van den Bergh BR, Mulder EJ, Mennes M, Glover 
V. Antenatal maternal anxiety and stress and the 
neurobehavioral development of the fetus and 
child: links and possible mechanisms. A review. 
Neurosci Biobehav Rev 2005 29, 237-258. 
21. Brown GW, Harris T. Social origins of depression: a 
study of psychiatric disorder in women. 1978 Taylor 
& Francis. 
22. O’Hara MW, Swain AM. Rates and risk of postpartum 
depression-A meta-analysis. International Review 
of Psychiatry 1996 03;8(1):37-54.
23. Beck CT. Predictors of postpartum depression: an 
update. Nurs Res. 2001 Sep-Oct;50(5):275-85.
24. Klein DN, Kotov R, Bufferd SJ. Personality and 
depression: explanatory models and review of the 
evidence. Annu Rev Clin Psychol. 2010 7, 5.1-5.27.
25. Kotov R, Gamez W, Schmidt F, Watson D. Linking 
“big” personality trains to anxiety, depressive and 
substance use disorders: a meta-analysis. Psychol 
Bull. 2010 136, 768-821.
26. Ormel J, Oldehinkel AJ, Brilman EI. The interplay 
and etiological continuity of neuroticism, 
difficulties, and life events in the etiology of major 
and subsyndromal, first and recurrent depressive 





27. Hovens, JG, Giltay, EJ, Wiersma JE, Spinhoven P, 
Penninx BW, Zitman FG. Impact of childhood life 
events and trauma on the course of depressive and 
anxiety disorders. Acta Psychiatr Scand. 2012 126, 
198-207.
28. Robertson E, Grace S, Wallington T, Stewart DE. 
Antenatal risk factors for postpartum depression: a 
synthesis of recent literature. Gen Hosp Psychiatry. 
2004 Jul-Aug;26(4):289-95.
29. Nielsen Forman D, Videbech P, Hedegaard M, 
Dalby Salvig J, Secher NJ. Postpartum depression: 
identification of women at risk. BJOG 2000 
Oct;107(10):1210-1217.
30. Raisanen S, Lehto SM, Nielsen HS, Gissler M, 
Kramer MR, Heinonen S. Fear of childbirth predicts 
postpartum depression: a population-based 
analysis of 511 422 singleton births in Finland. BMJ 
Open 2013 Nov 28;3(11):e004047-2013-004047. 
31. Josefsson A, Angelsioo L, Berg G, Ekstrom CM, 
Gunnervik C, Nordin C, et al. Obstetric, somatic, 
and demographic risk factors for postpartum 
depressive symptoms. Obstet Gynecol 2002 
Feb;99(2):223-228. 
32. Patel RR, Murphy DJ, Peters TJ. Operative delivery 
and postnatal depression: a cohort study. BMJ 
2005 Apr 16;330(7496):879. 
33. Carter FA, Frampton CM, Mulder RT. Cesarean 
section and postpartum depression: a review of the 
evidence examining the link. Psychosom Med 2006 
Mar-Apr;68(2):321-330. 
34. Blom EA, Jansen PW, Verhulst FC, Hofman A, 
Raat H, Jaddoe VW, et al. Perinatal complications 
increase the risk of postpartum depression. The 
Generation R Study. BJOG 2010 Oct;117(11):1390-
1398.
35. Sword W, Landy CK, Thabane L, Watt S, Krueger P, 
Farine D, et al. Is mode of delivery associated with 
postpartum depression at 6 weeks: a prospective 
cohort study. BJOG 2011 Jul;118(8):966-977.
36. Adams SS, Eberhard-Gran M, Sandvik AR, Eskild 
A. Mode of delivery and postpartum emotional 
distress: a cohort study of 55,814 women. BJOG 
2012 Feb;119(3):298-305. 
37. Rauh C, Beetz A, Burger P, Engel A, Haberle L, 
Fasching PA, et al. Delivery mode and the course 
of pre- and postpartum depression. Arch Gynecol 
Obstet 2012 Dec;286(6):1407-1412. 
38. NICE CG192 2015, National Institute for Health 
and Clinical Excellence (NICE). Antenatal and 
postnatal mental health, clinical guideline 45. The 
British Psychological Society & The Royal College 
of Psychiatrists 2007.
39. American College of Obstetricians and 
Gynecologists Committee Opinion no. 630. 
Screening for perinatal depression. Obstet 
Gynecol. 2015 May;125(5):1268-71. 
40. Stowe ZN, Nemeroff CB. Women at risk for 
postpartum-onset major depression. Am J Obstet 
Gynecol. 1995 Aug;173(2):639-45.
41. De Boer J, Zeeman K. KNOV Standaard Prenatale 
Verloskundige Begeleiding, 2008
42. Spijker J, Bockting CLH, Meeuwissen JAC, Vliet IM 
van, Emmelkamp PMG, Hermens MLM, Balkom 
ALJM van namens de Werkgroep Multidisciplinaire 
richtlijnontwikkeling Angststoornissen/Depressie 
(2013). Multidisciplinaire richtlijn Depressie (Derde 
revisie). Richtlijn voor de diagnostiek, behandeling 
en begeleiding van volwassen patiënten met een 
depressieve stoornis. Utrecht: Trimbos-instituut. 
43. Goodman JH. Women’s attitudes, preferences, 
and perceived barriers to treatment for perinatal 
depression.Birth. 2009 Mar;36(1):60-9.
44. Ross LE, Grigoriadis S, Mamisashvili L, 
Vonderporten EH, Roerecke M, Rehm J, Dennis 
CL, Koren G, Steiner M, Mousmanis P, Cheung 
A. Selected pregnancy and delivery outcomes 
after exposure to antidepressant medication: 
a systematic review and meta-analysis. JAMA 
Psychiatry. 2013 Apr;70(4):436-43.
45. Beck AT. The current state of cognitive therapy: a 
40-year retrospective. Arch Gen Psychiatry 2005, 
62:953-959. 
46. Cuijpers P, van Straten A, van Schaik A, Andersson 
G. Psychological treatment of depression in 
primary care: a meta-analysis. Br J Gen Pract. 2009 
Feb;59(559
47. Barker DJP, Osmond C. Infant mortality, childhood 
nutrition and ischaemic heart disease in England 
and Wales. Lancet 1986;I: 1077-81.
 

Associations of life events during 
pregnancy with longitudinal change 















To investigate the association of life events during pregnancy with change in antenatal 
anxiety and depression symptoms. We distinguished pregnancy related and non-pregnancy 
related events and assessed specificity of these associations for depressive or anxious 
symptoms. In addition, we investigated whether the associations were affected by personality 
or childhood adversities.
Measurements and findings
1,603 women during their first trimester of pregnancy were included between May 2010 
and May 2012. We associated pregnancy related and non-pregnancy related life events, 
childhood adversities and the personality traits neuroticism and extraversion with the change 
in symptoms of anxiety (State Trait Anxiety Inventory) and depression (Edinburgh Postnatal 
Depression Scale) from week 12 to week 36.
Life events during pregnancy were associated with increasing antenatal symptoms 
of anxiety and depression. Effect sizes associated with the highest numbers of events 
observed ranged from 0.59 to 1.31. Pregnancy related events were specifically associated 
with increasing symptoms of anxiety, whereas non-pregnancy related events were merely 
associated with an increase in symptoms of depression. Neither personality traits nor 
childhood trauma influenced the associations under study. 
Key conclusions
Compared to pregnancy related events, non-pregnancy related events show stronger 
associations with increases in symptoms of anxiety or depression. Pregnancy related life 
events during pregnancy increase levels of antenatal anxiety, whereas depression levels 
increase when women experience life events that are unrelated to pregnancy. There was 
no evidence of modification of these associations by neuroticism, extraversion or childhood 
trauma.
Implications for practice
Our findings may help midwifes to tailor psychosocial care to the specific risks of the 





During pregnancy, 10-15% of all women experience mild to moderate symptoms of 
anxiety or depression1,2. In addition to the burden to women themselves, these symptoms 
are associated with unfavorable obstetric outcomes, as well as with an adverse cognitive, 
motor and psychosocial development of the child3,4. 
The most consistent predictor of depression in both the general population5,6and 
pregnant women7, is having experienced life events. However, studies among pregnant 
women mostly considered events that happened before pregnancy, ignoring life events 
experienced during pregnancy. Recency of a life event, however, has shown to be associated 
with particularly high levels of anxiety or depression8. Therefore, stressors that occur during 
pregnancy, e.g. physical problems9, are likely to have a higher impact on antenatal symptoms 
of anxiety or depression than those occurring before pregnancy. Moreover, we hypothesize 
that in particular life events that are specifically related to pregnancy might trigger anxious 
or depressive feelings. As far as we know, neither life events during pregnancy as a separate 
category nor specific pregnancy related life events have been investigated in relation to 
change in levels of antenatal anxiety or depression to date.
Besides the experience of life events, personality traits are known to be closely linked to 
psychopathology10,11. High levels of neuroticism and low extraversion are not only directly 
associated with depression and anxiety. They have also shown to modify the promoting 
effects of life events on the onset and maintenance of psychopathology in such a way that 
being high neurotic or low extraverted makes people more vulnerable to become anxious or 
depressed when experiencing negative life events6. 
In addition to personality traits, a history of traumatic childhood events such as physical 
or sexual abuse or loss of a parent have been suggested as modifiers of the association of 
adult life events with psychopathology. Indeed, having experienced childhood trauma makes 
people more vulnerable to depression in adult life5,12.
It is presently unknown whether the aforementioned relationships are any different 
during pregnancy. Animal studies have shown that female brains change during the transition 
to motherhood and that these changes might lead to a change in their behavior13. Women 
may therefore respond differently to an event during pregnancy than outside pregnancy, and 
personality traits as well as childhood events may play a disparate role herein. 
The present study is the first to investigate the change in symptoms of antenatal anxiety 
or depression associated with life events during pregnancy making a distinction between 
pregnancy and non-pregnancy events. The specificity of these associations for depressive 
chapter 
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symptoms and symptoms of anxiety is investigated as well as their potential modification by 
neuroticism, extraversion and childhood trauma.
Methods
Subjects
The present study was carried out within the ongoing Pregnancy, Anxiety and Depression 
(PAD) Study. This is a prospective cohort study that was set up to investigate symptoms of 
and risk factors for anxiety or depression during pregnancy and the first year postpartum. All 
pregnant women visiting primary and secondary obstetric care centers in the Netherlands 
during their first trimester are invited, and those who participate are followed up until 12 
months postnatal. The study protocol was approved by the medical ethical committee of the 
University Medical Centre Groningen.
For the present study we included 3,358 women that were screened at a pregnancy 
duration of around 12 weeks from May 2010 to May 2012. By the end of that period, 101 
primary and 7 secondary obstetric care centers were participating.  Follow-up in the current 
study was collected at a pregnancy duration of approximately 36 weeks.
Response, follow-up and missing data
Out of 3,358 women responding to the baseline screening questionnaire, 1,603 (48%) 
also filled out the follow-up questionnaires and formed the study population for the present 
analysis. The majority of women who did not respond to the follow-up questionnaire had 
pregnancy durations of less than 36 weeks or gave birth before even reaching this duration 
and was therefore not eligible to be included in the present study. Women with pregnancy 
durations of 36 weeks or more who had not responded to the follow-up questionnaire, 453 
in number (26%), showed no marked differences with those who did complete the follow-
up assessment, with respect to mean baseline anxiety and depression, personality scores, 
number of life events, parity, age, educational level or income. 
The percentage of missing data in the present study ranged from 3.5 to 37.1 for the 
variables of main interest; anxiety (3.7%), depression (4.2%), childhood trauma (3.5%), 
non-pregnancy related events during pregnancy (37.3%), pregnancy related events during 
pregnancy (35.1%), neuroticism (5.2%) and extraversion (4.4%). The percentage of missing 




Complete case analysis can give biased results and exclusion of patients with missing data 
will decrease the statistical power of a study14 . Missing values for all variables except for the 
outcome variables were imputed because it has been shown that when outcome measures 
are not imputed, the precision of a study is generally larger 14.
Missing data was imputed using multiple imputation by chained equations under the 
assumption that missing values were missing at random or missing completely at random. 
Multiple data sets (N=5) were generated to account for the uncertainty in imputed data. The 
regression coefficients and standard errors were pooled using Rubin’s method for multiple 
imputation inference15.
Imputation and all analyses were carried out using STATA MP 11.0.
Instruments
Anxiety, depression were measured at both baseline and follow-up. Personality traits, 
childhood trauma and measures on all potential confounders were assessed at baseline, and 
life events during pregnancy were assessed at follow-up.
The 6-item State Trait Anxiety Inventory (STAI) was used for the measurement of anxiety. 
This shortened version has demonstrated to be as valid as the original 20-item STAI16. Scores 
≥42 indicate moderate to high levels of anxiety.  
The Edinburgh Postnatal Depression Scale (EPDS) was used to measure state of depressive 
symptoms and has shown to be valid for both pregnant and postnatal women17. A cut-off 
score ≥12 indicates a moderate to high level of depression.
Data on life events during pregnancy was collected using a 50-item questionnaire 
developed in the Avon Longitudinal Study of Parents And Children (ALSPAC)18. This 
questionnaire measures life events regarding employment, marital problems, illness or death 
of loved ones, abuse of either the mother or one of her children and substance misuse in her 
family. In addition, it contains questions on life events that relate to pregnancy, i.e. testing 
for congenital anomalies, test results indicating that the baby might have abnormalities, 
being told that it is a twin pregnancy, finding out that the partner does not want to have 
the baby, bleeding and being afraid to miscarry, trying to get an abortion, and finding out 
that something that happened might be harmful to the baby. For the analyses, we used 
the number of life events during pregnancy categorized as general life events or life events 
related to pregnancy. 
We defined childhood trauma as the occurrence of an event before the age of 16 that is 
generally considered relevant for developing emotional symptoms12. It was analyzed as the 
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number of positive responses to the following items from the Life Events Scale (CERQ)19: loss 
of a parent due to divorce or death, severe mental illness of a parent, substance misuse in 
family of origin, violence in family of origin, physical abuse and sexual abuse.
The Dutch version20 of the NEO Five Factor Inventory (NEO-FFI) was used to assess 
personality traits. The NEO-FFI is a shortened version of the NEO-Personality Inventory-
Revised (NEO-PI-R), has proved to be valid and has an internal consistency ranging from 
0.68 to 0.8621. This instrument consists of 60 items covering the five major dimensions of 
personality; neuroticism, extraversion, openness, agreeableness and conscientiousness. 
A 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree) was used for 
the responses. In the present study, the dimensions neuroticism and extraversion were 
considered only because of their established relation with psychopathology10,11.
Potential Confounders 
Several a priori potential confounders were considered: marital status (married yes/no), 
maternal age at baseline, social support assessed by asking a rank for the satisfaction of the 
perceived support in specific situations on a scale from 1 to 6, primiparity (yes/no) and socio-
economic position. Socio-economic position was calculated as the equally weighted average 
of the educational attainment level of the respondent, her partner, and their total income. 
Statistical Analysis
To compare effect sizes between the associations studied, we started by creating Z-scores 
for personality traits, depression and anxiety. Numbers of life events were standardized to a 
continuous number between 0 and 1. This was done by dividing the number of events for 
each woman by the maximum number of events that had occurred within each category 
of life events, and then analyzed as continuous variables. Consequently, coefficients from 
subsequent regression analyses indicated the effect size (Cohen’s d) of a difference between 
no life events and the maximum number of life events per category.  
A paired t-test was performed to evaluate whether changes in levels of anxiety and 
depression between baseline and follow-up were statistically significant.
The associations of life events, childhood trauma and personality traits with the mean 
change of symptoms of anxiety and depression from baseline to follow-up were analyzed 
using linear regression models. Mean change of symptoms was analyzed as the follow-
up level adjusted for its baseline value. First, the two distinct categories of life events, 
childhood trauma and both personality traits were entered separately as predictor variables. 
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As depression and anxiety are often comorbid, we additionally investigated specificity of 
the associations for either anxiety or depression by adjusting the analysis of anxiety for 
baseline and follow-up depressive symptoms, and vice versa. Second, we analyzed whether 
the associations of life events with symptom levels were modified by personality traits and 
childhood trauma. This was done by entering interaction terms for these variables and each of 
the life event variables, next to their main effects, and assessing their statistical significance. 
In each regression analysis, potential confounders were added as independent variables 
and the amount of change in the coefficients of the variables of interest was assessed. The 
change was considered a measure of the extent of confounding. Confounders with substantial 
effects (>10%) were retained in all regression analyses.
Findings
At both baseline and follow-up, symptoms of antenatal anxiety were more prevalent 
than those of depression. Slightly more women experienced symptoms of anxiety at follow-
up (N=219, 14%) compared to baseline (N=199, 12%). The prevalence of depression did not 
change during follow-up (N=98, 6%). 
Table 1 shows that most women were medium to highly educated, and their total family 
income was generally modal. An ample half of all women experienced specific pregnancy 
related events during pregnancy (57%), whereas non-pregnancy related events were more 
common (78%). Childhood trauma was experienced by 26% of women. Mean levels of anxiety 
and depression slightly increased from baseline to follow-up in a statistically significant 
way (p<0.001). Subsequent regression analyses indicated that none of the confounders 
considered had a substantial influence on the associations. Therefore, they were not included 
in the final models.
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Table 1 Characteristics of the study population (N=1,603)
Maternal age in years, mean (min-max) 30 (17-46)
Primiparae, N (%) 655 (41%)
Education, N (%)
Elementary education 5 (0,3%)
Lower  tracts of secondary education 71 (4%)
Higher tracts of secondary education 609 (38%)
Higher vocational education 640 (40%)
University education 278 (17%)
Total family income N (%)
0 – 30.999 euros 294 (18%)
31.000 – 59.999 euros 823 (51%)
60.000 euros or more 486 (30%)
Pregnancy related life events a 
One or more, N (%) 914 (57%)
Median number (min-max) 1 (0-4)
Non-pregnancy related life events a
One or more, N (%) 1250 (78%)
Median number (min-max) 2 (0-20)
Childhood adversities b
One or more, N (%) 417 (26%)
Median number (min-max) 0 (0-6)
Anxiety (STAI) baseline level c, mean (SD) 32.35 (8,41) 
Anxiety (STAI) follow-up level d, mean (SD) 32.96 (9,20)
Depression (EPDS) baseline level c,  mean (SD) 4.32 (3,52)
Depression (EPDS) follow-up level d,  mean (SD) 4.93 (3,68)
STAI – Spielberger State Trait Anxiety Inventory (min-max 20-80)
EPDS – Edinburgh Postnatal Depression Scale (min-max  0-30) 
a  experienced during pregnancy
b  before age of 16
c  pregnancy duration of 12 weeks
d pregnancy duration of 36 weeks
page
27
Table 2 shows the associations of the two categories of life events, childhood trauma, 
and both personality traits with the change in symptoms of anxiety and depression from 
baseline to follow-up. 
Both types of life events, non-pregnancy related and pregnancy related, showed 
a statistically significant association with increasing levels of antenatal symptoms of 
anxiety and depression. These associations were monotonous and approximately linear. 
Effect sizes associated with the maximum number of events compared to no events were 
moderate to very large, i.e. ranged from 0.59 to 1.31. Compared to pregnancy related 
events, non-pregnancy related events showed stronger associations with increases in 
these symptoms. Life events that were related to pregnancy were still associated with 
the change in anxiety when correcting for depression, which indicates specificity of the 
association for anxious symptoms. Conversely, non-pregnancy related events merely had 
a statistically significant influence on change in depression when corrected for anxiety. 
Childhood trauma was not associated with change in antenatal symptoms of anxiety or 
depression. Personality traits did show a statistically significant association; higher levels 
of neuroticism as well as lower levels of extraversion were associated with increasing levels 
of antenatal symptoms of anxiety and depression. 
There was no statistically significant modification by the personality traits or childhood 
trauma of the associations between life events during pregnancy and change in anxious or 

























































































































































































































































































































































































































































































































































































































































































In the present prospective cohort study, we investigated associations of pregnancy 
related and non-pregnancy related life events during pregnancy with longitudinal change in 
symptoms of antenatal anxiety or depression. We studied the specificity of the associations 
for anxiety or depression, and the potential modification of the associations by specific 
personality traits and childhood trauma. 
We demonstrated that in general higher numbers of life events that had occurred during 
pregnancy were associated with increasing antenatal symptoms of anxiety or depression 
from 12 to 36 weeks of pregnancy. Non-pregnancy related events showed stronger 
associations than pregnancy related events. Pregnancy related events were specifically 
associated with increasing symptoms of anxiety, whereas non-pregnancy related events 
were merely associated with an increase in symptoms of depression. Further, we observed 
that higher levels of neuroticism and lower levels of extraversion were associated with 
increasing symptoms of both anxiety and depression, and that childhood trauma did not 
predict changes in symptoms of anxiety or depression. Neither neuroticism, nor extraversion, 
nor having experienced childhood trauma moderated the associations between life events 
and symptoms of anxiety or depression. 
Contrary to our hypothesis pregnancy related events were less strongly associated 
with antenatal increases of anxiety or depression than non-pregnancy related events. 
Interestingly however, pregnancy related events were differentially associated with type 
of symptomatology, i.e. especially increases in anxiety were explained by these events. 
Conversely, non-pregnancy related events associated with development of depressive 
symptoms. This makes sense, as it is very likely that a woman’s first response to an event such 
as hearing that prenatal screening results indicate that something might be wrong with the 
baby is worrying about the future of her child, whereas an event like the loss of a loved one 
is more likely to trigger feelings of depression. It is important to note that antenatal anxiety 
might have a larger impact on the child’s neuromotor development than depression during 
pregnancy22. 
A limited number of studies have been conducted on psychological outcomes after 
experiencing specific pregnancy related events during pregnancy. Most studies addressed 
prenatal testing and diagnosis. Kowalcek (2003) found that women had higher anxiety levels 
both before and after prenatal testing, especially when they had a positive test result23. In 
addition, at the time of prenatal screening24 or shortly after the diagnosis of an anomaly25, 
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the majority of women in their respective samples had higher stress levels. In line with our 
finding is that a prenatal diagnosis of congenital heart disease was associated more with 
anxiety than with depression26. Nevertheless, results of the only randomized controlled 
trial on this topic conducted by Kleinveld et al. (2006) demonstrated that offering prenatal 
screening did not increase subsequent anxiety levels27. Our findings largely corroborate those 
obtained in a large cohort study showing that various pregnancy related and non-pregnancy 
related stressors went with increases in both antenatal anxiety and depression28. They did 
not demonstrate that specifically pregnancy related factors were associated with anxiety 
rather than depression. However, this study was cross-sectional with data collected at 
varying pregnancy durations. Another cross-sectional study showed that several pregnancy 
and non-pregnancy related events were associated with emotional and somatic distress but 
in the analyses no distinction between the two types of events was made29.
As to the associations between personality traits and anxiety or depression, research has 
mostly been conducted in men and non-pregnant women10,11. We observed in our study that 
both high neuroticism and low extraversion are associated with increasing levels of both 
antenatal anxiety and depression, not contradicting our hypothesis that during pregnancy 
the associations of these traits with antenatal anxiety and depression are different13.
We further hypothesized that the association between life events during pregnancy 
and the change in symptoms of antenatal anxiety or depression is modified by personality 
traits or childhood trauma. However, none of the pertaining interactions were substantial 
or significant. This is contrary to our expectation. Spinhoven et al. (2010) considered 
neuroticism as a modifier30; however, they studied this personality trait as a modifier in the 
association between childhood trauma and anxiety or depressive disorders, whereas we 
considered childhood trauma to be an effect modifier itself. In addition, our study did not 
consider disorders but subsyndromal symptoms. 
Our findings did not identify childhood trauma as an effect modifier; which may indicate 
that having experienced childhood trauma does not make women more vulnerable to 
an adverse impact of life events during pregnancy. These findings are supported as well 
as contradicted by previous studies. For example, Comijs (2007) did not find evidence for 
moderation of the association between life events and depression or anxiety by childhood 
trauma31. However, this study consisted of an elderly population in which most reported 
childhood traumas were related to the Second World War. On the other hand, Brown and 
Harris (1978) found a moderating effect of a specific traumatic event5, i.e. loss of the mother 
during childhood, on the association of recent stressful life events and ongoing difficulties. 
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Further, Bifulco et al. (2000) found that in particular the combination of childhood trauma 
and negative life events in adulthood predicted recurrent depressive episodes in women32. A 
possible explanation for the discrepancy of the findings in these studies with our observations 
is that they included people with anxiety or depressive disorders, not subsyndromal 
symptoms. 
A few limitations of this study need to be considered. First, all assessments on life events 
were done using retrospective self-report checklists, which may be prone to recall bias. 
People with mental health problems tend to over-report the number and severity of stressors 
that they have experienced33. We used the number of life events and not the perceived 
severity to minimize this potential bias. Second, current affective state might influence the 
assessment of personality10. However, when we excluded women with moderate to high 
levels of anxiety or depression at baseline, results were similar. Third, the items measuring 
neuroticism in the NEO-FFI and the items of the EPDS are alike, which might have inflated 
the associations between depression and personality traits10. However, the time frames of 
both measurements differ; EPDS measures state (‘how do you feel at this moment’), whereas 
NEO-FFI measures trait (‘how do you usually feel’). Finally, although we observed increasing 
anxiety and depression associated with life events, mean scores remained below the cut-off 
value for subclinical and clinical disorders. Therefore our results are not necessarily applicable 
to pregnant women with anxiety or depressive disorders. Nevertheless, having subthreshold 
symptoms of depression is a risk factor for developing a clinical disorder as convincingly 
shown in a systematic literature review34.
These limitations are potentially offset by strengths of this study. First, the sample size 
was considerable and as far as we know one of the largest in this field. Further, the present 
study is the first to investigate specific pregnancy related events compared to general 
types of events, and interactions between these categories and personality traits as well as 
childhood trauma. Finally, this study was the first to consider longitudinally assessed change 
in symptoms of antenatal anxiety or depression in relation to events during pregnancy. This 
approaches makes reverse causality, i.e. the events were induced by declining mental health 
unlikely. Furthermore, symptoms measured at a single time point in pregnancy may be the 
result of enduring depression or anxiety that started before pregnancy.
In conclusion, the present study shows that women do not essentially respond differently 
to a life event during pregnancy than outside pregnancy. Compared to pregnancy related 
events, non-pregnancy related events have more substantial associations with increases in 
symptoms of anxiety and depression. The study also shows that during pregnancy, events 
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that are related to pregnancy go with increases in anxiety, whereas levels of depression 
increase in association with non-pregnancy related events. We found no evidence of 
modification of these associations by neuroticism, extraversion or childhood trauma. Our 
findings may help midwifes to tailor psychosocial care to the specific risks of a woman and 
thereby to contribute to the health of mother and child.
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What if pregnancy is not seventh heaven? 
The influence of specific life events during 
pregnancy and delivery on the transition 














Postpartum symptoms of anxiety and depression are known to have a negative impact 
on mother and child and major life events constitute a major risk factor for these symptoms. 
We aim to investigate to what extent specific life events during pregnancy, delivery 
complications and antenatal anxiety or depression independently contribute to the risk of 
these symptoms in the postpartum period and whether they interact.
Methods
Within a prospective population-based cohort study (n=3,842) in the Netherlands, 
antenatal symptoms of anxiety or depression were measured at the end of the first 
trimester and at five months postpartum. Antenatal life events were assessed during the 
third trimester, information on delivery complications was obtained from midwives and 
gynecologists. Linear regression analyses were performed to study change in symptoms 
over time associated with specific events. In addition, modification of these associations by 
antenatal anxiety and depression levels was tested. 
Results
Women with elevated levels of anxiety or depression in their first trimester are at 
increased risk of these symptoms at five months postpartum. The experience of a life event 
that was related to health and sickness of self or loved ones, to the relation with the partner 
or conflicts with loved ones, or to work, finance or housing problems was significantly 
associated with higher postpartum levels of anxiety (p<0.001) and depression (p<0.001). 
None of the associations between postpartum levels of anxiety and depression and the 
experience of an eventwas modified by antenatal levels of anxiety or depression. 
Conclusion
Elevated postpartum levels of anxiety and depression were strongly associated with 
increased antenatal levels of anxiety and depression. Experiencing life events during 
pregnancy that were related to the pregnancy, the mode of delivery or the newborn were 
found not to be associated with an increase in levels of anxiety and depression. This is not 




Reproductive age is a period in life in which women are vulnerable to the impact of 
symptoms of anxiety or depression. During and outside pregnancy alike, prevalence rates of 
these symptoms range from 8 to 15%e.g. 1-12 . Antenatal symptoms of anxiety or depression are 
the most important risk factor for the occurrence of these symptoms postpartum3,13-17, which 
in turn has been associated with insecure mother-child attachment18,19. In addition, these 
symptoms during pregnancy have been associated with several obstetric adverse outcomes 
in the child, such as preterm birth and low birth weight20-22, as well as emotional, cognitive 
and behavioral problems13,22-25. 
Well-known risk factors for antenatal anxiety or depression are a history of anxiety or 
depression, low partner support, lower socioeconomic status, specific personality traits 
and major life eventse.g. 9,26. Studies among pregnant women commonly classified  recent 
major life events as general types of events during pregnancye.g. 14,27, while other studies 
focused on pregnant women who are facing stress due to specific conditions, i.e. obstetric 
complications28,29. A few population-based studies however, have shown that specific 
pregnancy related events are likely to increase symptoms of anxiety or depression during 
pregnancy12,30,31. 
Childbirth itself can also be considered a major life event, especially when the delivery 
was complicated, for example when the baby was delivered by an emergency caesarean 
section or the baby was admitted to the neonatal intensive care unit. During the past decade, 
there is a growing but inconclusive body of literature on the associations between delivery 
complications and postpartum symptoms of anxiety and depression32-38. 
A few large population-based cohort studies (n>5,000) found that experiencing obstetric 
events during pregnancy or events that were related to the condition of the newborn (i.e. 
low birth weight, preterm delivery, congenital malformations, admission to the hospital) 
increased the risk of symptoms of depression in the postpartum period31,39. However, both 
studies underline the consensual idea that a history of symptoms of depression is the main 
risk factor for symptoms of depression at a later moment in time. Nevertheless, there is 
no answer yet to the question to what extent the combination of antenatal symptoms of 
anxiety or depression and specific life events during pregnancy or delivery is associated with 
postpartum symptoms of anxiety or depression.
We investigated in a large population based cohort study to what extent specific life 
events during pregnancy, delivery complications and antenatal anxiety or depression 
independently contribute to the risk of these symptoms in the postpartum period and 
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whether they interact. 
Methods
Sample
Data was drawn from the prospective population-based Pregnancy, Anxiety and 
Depression (PAD) Study12, which has been designed to investigate symptoms of and risk 
factors for antenatal and postpartum symptoms of anxiety or depression. Midwives of the 
collaborating primary obstetric care centers (n=109) or hospitals (n=7) invited pregnant 
women at the first or second visit to participate. Due to logistic reasons it has been 
impossible to establish how many women were actually invited to the study. The number of 
included women was however considerably lower than we expected based on the number of 
participating centers. A survey among participating midwives indicated that time pressure 
caused the vast majority to not hand out the invitations to all visiting women, and that 
women who were under suspicion of having symptoms of either anxiety or depression 
were not specifically invited. Therefore, we have no reason to believe that, with respect 
to characteristics relevant to the study, responders and non-responders differed in any 
considerable way. After written informed consent was obtained, women were requested to 
fill out online baseline questionnaires at the end of the first trimester, and online follow-up 
assessments at the end of the second and third trimesters of pregnancy, as well as at five 
months postpartum. The medical ethical board of the University Medical Center Groningen 
approved the PAD-study. 
Data used for the current study was collected between May 2010 and March 2015. Women 
who were at least four months postpartum were eligible to be included, as participants had 
the opportunity to fill out the follow-up questionnaire online between four and seven months 
postpartum. Women who indicated that they wanted to withdraw from the study (n=676) 
or who did not give consent for retrieving information from their midwives (n=1,669), were 
excluded. This resulted in a sample of 3,842 women (52.8%). Of these women, 2,729 filled out 
the follow-up anxiety and depression questionnaires at five months postpartum, yielding a 
response rate of 72.1%. 
For postpartum measures of anxiety and depression, responders differed from non-
responders on the following baseline characteristics; they generally completed a higher 
education (p<0.02) and they were more often multiparous (p<0.04). In addition, non-
responders scored higher on antenatal measures of anxiety and depression compared to 
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women who did respond to the postpartum follow-up questionnaire, although mean scores 
on antenatal anxiety and depression measures were below the prevailing cut-offs for both 
responders and non-responders. Women who did not respond to the follow-up questionnaire, 
had experienced more general life events during pregnancy compared to women who did 
respond (p<0.05), although the means differed less than one event for all categories. 
Measurements
Baseline symptom levels of anxiety and depression measured at 12 weeks of estimated 
gestational age (range 5-19) and at five months postpartum (range 4-7) were analyzed. 
Life events during pregnancy were assessed during the third trimester. Maternal age and 
educational level were assessed at baseline. Educational attainment level was defined as the 
highest completed education, and divided into four categories; elementary or lower tracts 
of secondary education, higher tracts of secondary education, higher vocational education 
and university education. Socio-economic position was calculated as the equally weighted 
average of the educational attainment level of the respondent, her partner, and their total 
income. 
Antenatal and postpartum symptoms of anxiety were measured using the six-item state 
measuring version of the State and Trait Anxiety Inventory (STAI)40. Scores are on a scale 
from 20 to 80, with scores of ≥42 indicating an increased risk on anxiety40. 
To measure antenatal and postpartum symptoms of depression, we used the Dutch version 
of the ten-item Edinburgh Postnatal Depression Scale (EPDS)41. Scores range from 0-30. In 
line with Matthey42, we considered antenatal scores of 13 or above and postpartum scores of 
10 and above to indicate risk of minor or major depression. 
Data on life events during pregnancy was collected with a 46-item questionnaire, 
developed in the Avon Longitudinal Study of Parents And Children (ALSPAC)43. We divided 
the events into four categories; A) work, finance or housing problems, B) partner relation 
and conflicts with loved ones, C) health, and sickness of self or loved ones and D) pregnancy 
related. The first three comprise a total of 26 items on employment, illness or death of loved 
ones and marital problems. The latter category includes seven items that are related to the 
current pregnancy, e.g. undergoing tests on potential congenital anomalies of the fetus, 
being told that it is a twin pregnancy, finding out that the partner does not want to have the 
baby, or finding out that something that happened that might be harmful for the fetus. 
Information on mode of delivery and events that were related to the newborn was 
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retrieved from the midwives’ or gynecologists’ reports. We divided mode of delivery into 
A) unassisted vaginal delivery, B) instrumental vaginal delivery (i.e. forceps or vacuum 
extraction) and C) cesarean section, either elective of emergency. Events that relate to the 
newborn included preterm delivery (<37 weeks gestational age) and small for gestational age 
(i.e. >37 weeks gestational age but <2,500 grams). 
Statistical analyses
Descriptive statistics for demographic variables, number of life events and levels of 
anxiety or depressive symptoms were calculated. To allow for valid comparison of effect sizes, 
we created Z-scores for the antenatal symptoms of anxiety and depression. Subsequently, 
we performed a series of multivariable linear regression analyses to quantify the associations 
under study. In a separate analysis, potential confounders were added (i.e. socioeconomic 
position and nulliparity). To investigate associations with anxiety or depression specifically, 
analyses were additionally adjusted for depressive symptoms in the analysis of anxiety, and 
vice versa. 
Lastly, we assessed whether associations of specific life events and delivery complications 




Mean levels for anxiety and depression were rather stable from the antenatal to the 
postpartum period (table 1), although symptoms of depression significantly increased 
between the antenatal and postpartum period (mean difference = 0.33, p<0.001).
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Table 1 Characteristics of the study population (N=3,842)
Age at inclusion, mean (min-max) 31 (17-45)
Nulliparity, n (%) 972 (40,7%)
Educational level
Elementary or lower tracts secondary, n (%) 243 (8,5%)
Higher tracts secondary, n (%) 860 (30,0%)
Higher vocational , n (%) 1142 (39,8%)
University , n (%) 626 (21,8%)
No events related to the pregnancy a, n (%) 1551 (48,7%)
median (min-max) 1 (0-7)
No events related to health/sickness of self or loved ones a, n (%) 1950 (62,4%)
median (min-max) 0 (0-8)
No events related to partner relation/conflicts with loved ones a, n (%) 2445 (75,9%)
median (min-max) 0 (0-4)
No events related to work/finance/housing problems a, n (%) 1441 (45,2%)
median (min-max) 1 (0-10)
Mode of delivery, n (%)
spontaneous vaginal delivery 1768 (74,8%)
vacuum or forceps extraction 240 (10,2%)
sectio 356 (15,1%)
Newborn is preterm or has low birth weight, n(%) 148 (6,2%)
Baseline level anxiety (STAI) b, mean (SD) 32 (9,06)
Postpartum level anxiety (STAI) c, mean (SD) 32 (10,32)
Baseline level depression (EPDS) b, mean (SD) 4 (3,70)
Postpartum level depression (EPDS) c, mean (SD) 5 (4,06)
STAI – Spielberger State Trait Anxiety Inventory (min-max 20-80)
EPDS – Edinburgh Postnatal Depression Scale (min-max  0-30) 
a  experienced during pregnancy
b  pregnancy duration of 12 weeks






































































































































































































































































































































































































































































































































































































































































































































































































































Regression analyses of associations between experienced life events and 
postpartum levels of anxiety or depression
Antenatal symptoms of anxiety and depression were statistically significantly associated 
with postpartum level of anxiety and depression (p<0.001) (table 2). 
All categories of number of life events that are not related to the pregnancy, delivery or 
newborn were significantly associated with higher levels of anxiety and depression in the 
postpartum period. Adding potential confounders did not notably change the associations. 
When adjusting for postpartum levels of anxiety, all associations between life events and 
postpartum depression lost their statistical significance. For anxiety, this was only true for life 
events that were related to sickness and health of self or loved ones and life events related to 
the partner relation or a conflict with a love one. 
Moderation of the associations between experienced life events and postpartum 
levels of anxiety or depression by antenatal levels of anxiety and depression. 
The associations between number of life events and postpartum symptoms of anxiety 
was only moderated by antenatal anxiety in case of events related to sickness and health of 
self or loved one. None of the associations between antenatal life events and postpartum 
levels of depression were moderated by antenatal levels of depression.  
Discussion
The present study confirmed previous research showing that antenatal symptoms of 
anxiety or depression during pregnancy are strongly associated symptoms in the postpartum 
period. We showed that experiencing life events that were not related to the pregnancy, the 
mode of delivery or to the newborn were associated with elevated levels of anxiety and 
depression in the postpartum period. The association between postpartum levels of anxiety 
and events related to sickness and health of self or loved ones was found to be moderated by 
antenatal levels of anxiety.
Standardized effect sizes for levels of antenatal anxiety and depression were the highest of 
all predictor variables, indicating that antenatal symptomatology is the most important risk 
factor for having symptoms postpartum. This is in line with previous studies3,13-15,17. 
In our study, life events related to the partner relation or a conflict with a loved one, or to 
work, finance or housing problems increased the postpartum levels of anxiety and depression. 
In the general population, housing problems have been found to increase feelings of 
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stress44. Also, foreclosure induced a decline in mental health45. In addition, involuntary job 
loss and the past economic recession have been associated with higher suicidal rates46,47. 
However, this was not studied in specifically in pregnant women and especially found to be 
more prevalent in men. 
Experiencing a major recent life event is widely considered to be an important risk factor 
for depression. We therefore hypothesized that when maternal and neonatal outcomes 
were complicated, childbirth could be considered a major life event. Surprisingly neither the 
events related to delivery nor to the condition of the newborn were associated with change 
in levels of anxiety and depression symptoms. For mode of delivery, this is in line with most 
studies32,33,36,37. One study found that mode of delivery increased depression scores in the 
postpartum period in nulliparous women48. Their sample of women who had a caesarean 
section was however rather small (n=48). 
Strengths and limitations
Some limitations have to be borne in mind. First, symptoms of anxiety and depression 
were based on self-report questionnaires. Although both are commonly used in the 
identification of symptoms and have shown to have good validity40,41, no clinical diagnostic 
tools have been used in the present study to establish the severity of symptoms. Second, 
life events were assessed using a retrospective self-report checklist, which may have been 
prone to recall bias through its potential link with symptoms at the time of the assessments49, 
although the total sample was large, we had encountered a high percentage of missing data 
on events during delivery (38.5%) and events related to the newborn (38.1%). As the statistical 
power to demonstrate associations with a change in levels of anxiety and depression may 
thus be limited, these analyses should be considered exploratory.   
However, a major strength of the present study is the large, prospective, population based 
cohort (n=3,842). Additionally, to our knowledge, this study was the first to investigate the 
role of specific life events that are either more general or related to the pregnancy, delivery 
or newborn, in relation to the specific symptoms of anxiety or depression in the postpartum 
period. 
Concluding
Experiencing life events during pregnancy that were related to the pregnancy, the mode 
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of delivery or the newborn were found not to be associated with an increase in levels of 
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To investigate whether the ten-item Edinburgh Postnatal Depression Scale (EPDS) 
administered antenatally in 1,620 women in the general population is accurate in predicting 
postpartum depressive symptoms (EPDS score ≥10), and whether a two-item EPDS has 
similar predictive accuracy. 
Methods
Mean values, area under the receiver operating characteristics-curve (AUC), sensitivity, 
specificity and predictive values of antenatal EPDS for the likelihood of developing postpartum 
depressive symptoms were calculated. Analyses were repeated for each trimester, several 
cut-off values and a two-item EPDS (low mood and anhedonia).
Results 
Mean EPDS scores were significantly higher during each trimester in women with 
postpartum depressive symptoms, compared to those without (p<0.001). Using the prevailing 
cut-off (≥10), the AUC was reasonable (0.74), sensitivity was 26.3%, positive predictive value 
25.9%, specificity 93.0% and negative predictive value 93.1%. Using a lower cut-off value (≥5), 
sensitivity was 70.8% and specificity was 65.4%, but positive predictive value was low (15.9%). 
Negative predictive value was exceedingly high with 96.0%. Results were similar during the 
second and third trimester. The predictive accuracy of the two-item EPDS appeared inferior.
Conclusions 
The EPDS was not sufficiently accurate in predicting risk of postpartum depressive 
symptoms. Nevertheless, when using the ≥5 cut-off value, it may be adequate for initial 
screening, followed by further assessments and possibly antenatal intervention when 
positive. Furthermore, when negative, women may be reassured that postpartum depressive 




Depression affects 8-15% of women in the first year postpartum1-4. This poses a 
considerable burden to the women, their families and society5,6. Children born to women 
who experienced postpartum depression, are at risk of insecure attachment, which in turn 
is associated with cognitive, behavioral and emotional problems7,8. Moreover, postpartum 
depression is commonly preceded by antenatal depression4,9,10, which has been associated 
with unfavourable obstetric outcomes and impaired child neurodevelopment10-12, 
independent of effects due to postpartum depression11. Thus, timely detection of antenatal 
depressive symptoms is critical for mother and child. Correspondingly, the American College 
of Obstetricians and Gynecologists recommends antenatal screening13. 
The ten-item Edinburgh Postnatal Depression Scale (EPDS)14,15 is commonly used for 
assessing depressive symptoms, and was validated as antenatal and postpartum screener 
for minor or major depression16. While depressive symptoms are known to be associated 
with the development of a depressive disorder17, it is remarkable that predicting the absolute 
risk of postpartum depression, based on antenatal depressive symptoms as assessed by the 
EPDS, has been studied scarcely10,18,19. In a large cohort, the relative importance of several 
antenatal risk factors for postpartum depression was studied18. Yet, the predictive accuracy of 
the antenatal EPDS was quantified exclusively for a single cut-off value and not specified for 
trimester of pregnancy. In another large cohort, the pattern of depressive symptoms during 
pregnancy and in the postpartum period was studied, but not the predictive accuracy of the 
EPDS10. One study observed that when using a higher than commonly used cut-off in the 
second trimester, the EPDS was accurate in predicting depression at six weeks postpartum19. 
However, their study suffered from a high loss to follow-up rate. 
Consequently, the predictive accuracy of the EPDS for identifying an increased risk 
of postpartum depression is still unknown. At the same time, a brief, reliable self-report 
antenatal screener to predict the likelihood of minor or major postpartum depression would 
facilitate midwives and gynaecologists in daily clinical practice20, for example a screener that 
only includes the two key symptoms of depression, i.e. anhedonia and mood21.
In the current prospective study, we examined to what degree the ten-item EPDS 
administered during the first, second and third trimester of pregnancy, using various cut-
offs, is valid for the assessment of the absolute risk of postpartum depressive symptoms. 
Since a two-item version would be more convenient, we further investigated the predictive 





The present study was carried out within the ongoing population-based Pregnancy, 
Anxiety and Depression (PAD) Study22. This prospective cohort study has been set up 
to investigate symptoms of and risk factors for anxious or depressive symptoms during 
pregnancy and the first half year postpartum. All pregnant women in their first trimester 
of pregnancy, visiting a total of 109 collaborating primary obstetric care centers and seven 
hospitals in the Netherlands, are invited to participate. Written informed consent is obtained 
from each participant. After baseline assessments at the end of the first trimester, follow-
up assessments using online questionnaires take place at the end of the second and third 
trimesters of pregnancy, as well as at six months postpartum. 
Data used for the present study was collected from May 2010 to September 2012. By 
the end of that period, 4,157 women had completed the baseline assessments. The eligible 
population for the present analysis consisted of women who were six months postpartum by 
the time of the database closure (N=1,620, 39%). Out of these, 1,276 responded by filling out 
the questionnaires yielding a response rate of 78.8%. Non-responders did not significantly 
differ from responders on parity, educational level or antenatal depressive symptoms. 
However, non-responders were significantly younger (30 vs. 29 years, p<0.02).    
Measurements
Demographic and pregnancy related variables included in the present study were age, 
parity and educational level, and were assessed at baseline. Educational level was defined 
as the highest completed education, and was divided into five categories; elementary 
education, lower and higher tracts of secondary education, higher vocational education and 
university education.
The Dutch version of the ten-item Edinburgh Postnatal Depression Scale (EPDS) was 
used to measure symptoms of depression14. This version of the EPDS has shown good internal 
validity with a Cronbach’s alpha of 0.8214. The baseline EPDS was administered as part of the 
initial antenatal screening and each follow-up assessment wave. Total EPDS scores of ≥10 
indicate depressive symptoms at a level corresponding to an increased risk of minor or major 
depression14. The outcome of this study, i.e. postpartum depressive symptoms at six months 
after giving birth, was defined accordingly. 
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Multiple imputation of missing data
Complete information on all variables was obtained on 1013 (62.5%) women. The 
percentage of missing data ranged from 1.5 (EPDS at baseline) to 21.1 (postpartum EPDS) 
for the variables of main interest. Under the assumption that missing values were missing 
at random (MAR) or missing completely at random, we imputed missing data using multiple 
imputation by chained equations. This was done to avoid the potential bias and decreased 
statistical power associated with complete case analysis23,24. We substantiated our assumption 
of the missing data mechanism being MAR by, for each variable separately, predicting 
missingness using logistic regression. Independent variables were all variables that were 
considered potential predictors of missingness24 i.e. antenatal anxiety, age at baseline, parity 
and maternal educational level. The explained variance (Nagelkerke R2) from these analyses 
ranged from 7.1% to 63.2%, suggesting that at least in part data are MAR and imputation of 
missing values would likely improve the validity of our analyses. Multiple data sets (N=5) were 
generated to account for the uncertainty in imputed data. 
Data analyses
Descriptive statistics for demographic variables were calculated according to the 
likelihood of the presence of postpartum depressive symptoms. We tested whether the mean 
value of each antenatal EPDS differed between women experiencing postpartum depressive 
symptoms and those who did not, using an independent samples t-test. Additionally, we 
calculated the prevalence of antenatal depressive symptoms (EPDS ≥10) at each assessment. 
Subsequently, we evaluated the predictive accuracy of each antenatal EPDS in terms 
of sensitivity, specificity, predictive values and overall discriminatory power. We first 
constructed receiver operating characteristic (ROC) curves, by plotting the sensitivity against 
the 1-specifity for all possible cut-off values of antenatal EPDS. Informed by these curves, we 
constructed crosstabs using all possible cut-off values between 5 and 10, and calculated the 
measures of predictive accuracy. The overall discriminatory power of the EPDS independent 
of cut-off value was quantified as the area under the ROC-curve (AUC). The AUC can be 
interpreted as the extent to which the EPDS separates women with postpartum depressive 
symptoms from those without. Values of 0.70 to 0.80 indicate a reasonable AUC, 0.80 to 0.90 
a good one and values of 0.90 or above are interpreted as excellent25. 
The above analyses were repeated for the EPDS scores recorded in the second and third 
trimester. In addition, we quantified the prevalence and predictive accuracy of exceeding the 
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≥10 cut-off at all three antenatal assessments.
Subsequently, we examined the predictive accuracy of the two EPDS items that refer to 
the key symptoms of depression. These are items 2 for anhedonia and 8 for depressed mood, 
according to the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV)21.  We 
summed the ratings of these items to a total score. This two-item version ranged from 0-6, 
the first cut-off value we tested was ≥3. Based on the results, the ROC-curve and the fact that, 
according to the DSM-IV, a diagnosis of depression needs at least one of these two items to 
be answered positively, we subsequently tested a cut-off value of ≥1. 
Measures of predictive accuracy were supplied with 95% confidence intervals. Results 
were pooled using Rubin’s method for multiple imputation inference26. Multiple imputation 
and statistical analyses were carried out using IBM SPSS Statistics 20.
Results
Descriptives
Mean gestational age of the study population (N=1,620) was 14, 23 and 34 weeks at the 
baseline, second and third trimester measurement waves, respectively. Women were five 
(range 4-7) months postpartum at the final measurement. At baseline, 139 women (8.6%) 
experienced depressive symptoms according to the cut-off value of ≥10. These figures were 
154 (9.5%) and 164 (10.1%) at the second and third trimester measurements, respectively. 
One hundred and thirty-seven women (8.5%) experienced postpartum depressive symptoms, 
which is equal to their a priori risk. 
Table 1 shows that demographic factors were equally distributed among women with 
and without postpartum depressive symptoms. At each instance of administration, scores 
on the EPDS were statistically significantly higher in the group with postpartum depressive 
symptoms than in the group without postpartum symptoms of depression (p<0.001). 
Crosstabs
Table 2 shows parameters of predictive accuracy of the ten-item EPDS in the first 
trimester using cut-off values ≥10 and ≥5, as well as those for the two-item version using 
cut-off values ≥3 and ≥1. Although for the ten-item EPDS we tested all cut-off levels between 
those presented in table 2, we decided to show only the most clinically relevant results. 
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Table 1 Demographic characteristics of the study population (n=1,620) according to the 












Age, mean (min-max) 30.0 (17-46) 29.7 (18-43) 4.1%
Primiparae, N (%) 625 (41%) 52 (38%) 29.8%
Educational level, N (%) 30.1%
Elementary education 7 (<1%) 1 (<1%) -
Lower tracts of secondary education 139 (9%) 15 (11%) -
Higher tracts of secondary education 508 (34%) 46 (34%) -
Higher vocational education 596 (40%) 57 (42%) -
University education 233 (16%) 18 (13%) -
Depression level first trimester b, mean (SD) 3.91 (3.32) 7.48 (4.86) 1.5%
Depression level second trimester b, mean (SD) 4.62 (3.14) 8.79 (4.93) 18.2%
Depression level third trimester b, mean (SD) 4.67 (3.17) 8.83 (4.58) 16.7%
Depression level postpartum b, mean (SD) 3.81 (2.51) 13.36 (3.75) 21.2%
a According to Edinburgh Postnatal Depression Scale (EPDS), cut-off EPDS ≥10, min-max=0-30
b Based on EPDS at approximately 14 weeks pregnancy, min-max=0-30. Scores were statistically significantly 
 higher in the group with postpartum depressive symptoms than in the group without postpartum 
 symptoms of depression, with p ≤0.001
The ten-item EPDS using the ≥10 cut-off showed low sensitivity (26.3%) and high 
specificity (93.0%). However, the AUC of 0.74 was reasonable (figure 1). When we decreased 
the cut-off value to ≥5, the sensitivity increased to 70.8% and the specificity decreased to 
65.4%. Positive predictive values were low at all considered cut-off values, whereas all 
negative predictive values were high. Although the positive predictive value for a score 
higher than 10 in the first trimester was only 25.9%, this risk is three times higher as the prior 
risk of postpartum depressive symptoms, which was 8.5%. Lowering the cut-off for the two-
item version also showed higher sensitivity (59.1% vs. 12.4%) at the expense of the specificity 
and the positive predictive value (table 3). The AUC of the two-item version, i.e. 0.63, was 
considerably lower than that of the complete ten-item version. 
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Figure 1 Area Under the ROC Curve for baseline score Edinburgh Postnatal Depression 
 Scale (EPDS) a in the prediction of minor or major postpartum depressionb 
AUC of 1.0 is perfect prediction
a Based on ten-item EPDS at approximately 14 weeks pregnancy, min-max=0-30, pooled for all imputed 
 datasets.
b According to EPDS, cut-off ≥10, min-max=0-30
When test positive was defined as a score of ≥10 at all three measurements (N=50;3.1%), 
the positive predictive value increased to 40.0%, while the sensitivity decreased to 15.0%. The 
negative predictive value and the specificity remained high (92.5% and 97.9%, respectively).
All of the above analyses were repeated for the EPDS scores recorded in the second and 
third trimester. Results were essentially similar to those obtained using the first trimester 
scores. However, AUC’s were slightly higher for the ten-item EPDS with 0.77 and 0.78 at the 
second and third trimester, respectively. For the two-item version the AUC was 0.68 at the 
second trimester and 0.71 at the third. 
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Table 3 Test characteristics for predicting postpartum depressive symptoms from a 
 two-item version for antenatal depressive symptoms 
Cut-off ≥3 a 
(n=65, 4%) b
Cut-off ≥1 a 
(n=586, 36.2%) b
Sensitivity, % (95% CI) 12.4 (7.4-19.1) 59.1 (50.4-67.4)
Specificity, % (95% CI) 96.8 (95.7-97.6) 65.9 (63.5-68.4)
Positive Predictive Value, % (95% CI) 26.2 (16.0-38.5) 13.8 (11.1-16.9)
Negative Predictive Value, % (95% CI) 92.3 (90.8-93.6) 94.6 (93.0-95.9)
Area Under the Curve 0.63 -
a  Based on items 2 and 8 of the Edinburgh Postnatal Depression Scale (EPDS) at approximately 14 weeks 
 pregnancy, min-max=0-6
b  Number and percentage of women scoring above the used cut-off at baseline EPDS
Discussion 
Main Findings
In this prospective cohort study, we found that women who developed postpartum 
depressive symptoms had statistically significantly higher antenatal EPDS scores. Irrespective 
of trimester, the ten-item EPDS had reasonable overall discriminatory power, but low 
sensitivity at the prevailing cut-off (≥10). When using a lower cut-off (≥5), both sensitivity 
and specificity were around 70%. However, for both cut-off values, positive predictive values 
were low, whereas negative predictive values were exceedingly high. A two-item version of 
the EPDS, consisting of merely the two key symptoms of depression, demonstrated a poor 
predictive performance. In addition, the EPDS was accurate in detecting current depressive 
symptoms. In the context of potential hazardous child effects of antenatal depressive 
symptoms, it is important that these symptoms are acknowledged by screening health care 
professionals. 
Strengths and limitations
The present study is not without limitations. First, the EPDS is a self-report questionnaire 
and even though it is commonly used, based on the EPDS score we are merely able to 
identify women with a higher risk of depressive symptoms. However, almost 70% of women 
exceeding the threshold of 10 satisfy the criteria for a diagnosis of depression31. Second, 
anxiety and depression are known to be co-morbid and several studies have shown that 
page
61
antenatal anxiety is a predictor of postpartum depression32,33. However, because the only aim 
was to test the predictive accuracy of the EPDS, anxiety is considered beyond the scope of 
the current paper, and should therefore be addressed in future research. Finally, although 
our antenatal prevalence rates (9-10%) are comparable with other studies1,2, women 
experiencing depressive symptoms in their first trimester might have been more inclined 
to participate than women who are not familiar with depressive symptoms. In addition, 
we found a significant difference in age between the respondents and non-respondents. 
However, in absolute numbers the age difference is less than a year; therefore we do not 
think it affected our prevalence rates. Likewise, the prevalence of postpartum depressive 
symptoms in our study was relatively low (8%). Previous studies reported prevalence rates 
of 8-15%1,2. However, in these studies, the time at which postpartum depressive symptoms 
were assessed ranged from a few days after delivery to two years postpartum, which may 
have caused the inclusion of maternity blues, thereby falsely increasing the prevalence of 
postpartum depression.
Our study also has several strengths. The present study is the first to date to examine 
the EPDS as a tool for antenatal assessment of the risk of postpartum depressive symptoms, 
during each trimester of pregnancy, evaluating several cut-off values for the sum score, as 
well as the possibility of item reduction. In addition, the present sample is a large prospective 
cohort, including 1,620 pregnant women in their first trimester, with a response rate of 78.8%. 
Interpretation
Despite reasonable overall discriminatory power, the EPDS appears to have limited 
predictive accuracy for absolute risk stratification, regardless of the cut-off value used or the 
trimester of administration, partly contradicting the findings of Lau et al.19. They concluded 
that when using a cut-off of ≥15, the EPDS during the second trimester of pregnancy appeared 
to be an accurate predictor of depression at six weeks postpartum, with parameters of 
predictive accuracy ranging from 63% to 85%, and an overall AUC of 0.76, the latter being 
in line with our findings. However, they suffered from a high loss to follow-up rate (72%), 
making the results susceptible to serious bias. From a more general point of view, Austin & 
Lumley concluded that no currently available antenatal screener is sufficient in predicting 
postpartum depression, due to the evidence that multiple risk factors are postpartum, which 
clearly cannot be included in antenatal screening27. Additionally, Milgrom et al. showed that 
adding prior history of depression and low partner support to antenatal EPDS yielded a 
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more accurate overall prediction, using a cut-off of >12, mainly administered during the third 
trimester18. They observed a low positive predictive value of 29%, which seems compatible 
with our findings; although the absolute risk of postpartum depressive symptoms for women 
scoring ≥5 was two times higher than the prior risk, it was still low (15.9%). In order to allocate 
interventions as much as possible to women who have a high risk of postpartum depressive 
symptoms, a two-stage screening may therefore be advocated, as previously suggested20. 
Women with an EPDS score of ≥5 during the first trimester can be screened more elaborately 
on well known risk factors, such as history of depression and low partner support, to decide 
whether an antenatal intervention is necessary. 
In suggesting a two-stage screening, the exceedingly high negative predictive value of 
the ten-item EPDS seems important. Women who scored <5 at the antenatal screening had a 
very low risk of postpartum depressive symptoms (4.0%). As previously suggested29, it could 
therefore be used to exclude women who are not at risk for depressive symptoms. However, 
due to the lowered cut-off, considerably more women were identified as having a high risk 
of postpartum depressive symptoms, comparable to the number of women identified with 
the two-item version. In that context, it could be argued that, as an initial screener, the two-
item version would be more facilitating in daily clinical practice. The National Institute for 
Health and Clinical Excellence (NICE) recommends a two-item dichotomous screening tool 
based on the key symptoms of depression30. However, this tool was developed with the only 
purpose of detecting current depressive symptoms20, in which it appears to be accurate20,28,29. 
In the present study, the two-item version also showed satisfactory predictive accuracy in the 
identification of current depressive symptoms, but the overall test parameters for predicting 
postpartum depressive symptoms are considerably lower. Therefore, in screening for high 
risk on postpartum depressive symptoms, we would suggest the use of the ten-item EPDS 
with a cut-off of ≥5.
Our study results do not suggest that timing of administering the EPDS during pregnancy 
affects its predictive accuracy. This is an important notion in view of the potential hazardous 
child effects of antenatal depressive symptoms, as this means that postponing screening 
for depressive symptoms cannot be justified by the argument that the predictive accuracy 




In conclusion, we found that in no trimester of pregnancy the EPDS is a sufficiently accurate 
instrument to identify women with a high risk of symptoms of postpartum depression. 
However, when using a lower than commonly used cut-off value, the test characteristics 
were such that a stepwise approach using the EPDS as a first screening step could be 
recommended to clinicians, midwives and gynaecologists. Women with a high risk (i.e. EPDS 
score of ≥5 during the first trimester) can subsequently be screened more elaborately on 
well known risk factors, such as a history of depression and low partner support, to decide 
whether an antenatal intervention is necessary. Women scoring <5 on the antenatal ten-item 
EPDS can be reassured that it is very unlikely that they will develop a postpartum depressive 
symptoms. Although it would be convenient to use a brief screener in daily clinical practice, 
a two-item version showed poor predictive accuracy. Because the predictive accuracy of the 
ten-item EPDS was similar across the three antenatal administrations, there seems to be no 
reason to postpone screening and possible intervention until after the first trimester.  
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To investigate whether the six-item State and Trait Anxiety Inventory (STAI) assessed 
antenatally is accurate in predicting postpartum symptoms of anxiety, and whether antenatal 
Edinburgh Postnatal Depression Scale (EPDS) can improve the prediction.
 
Methods 
A prospective, population-based cohort study in the obstetric care in the Netherlands, 
n=4,856. Mean values, odds ratios, area under the receiver operating characteristics curve 
(AUC), sensitivity, specificity and predictive values of antenatal STAI for the risk of postpartum 
symptoms of anxiety (STAI score ≥42) were calculated. Analyses were repeated for each 




The AUC was only reasonable in the second and third trimester (0.73). Using the prevailing 
cut-off (≥42) in the first trimester, the odds ratio was 3.49 [95%CI 2.61, 4.67]. Adding 
symptoms of depression did not improve the prediction. Sensitivity and positive predictive 
value were approximately 30%, specificity and negative predictive value were around 90%. 
Using a lower cut-off value (≥36) in the second trimester, sensitivity and specificity were 
both approximately 67%, but positive predictive value was low (22.9%, [95%CI 21.0, 24.9]). 
Negative predictive value increased to 93.2% [95%CI 92.3, 94.1]). 
 
Conclusions 
The six-item STAI was not sufficiently accurate in predicting risk of postpartum symptoms 
of anxiety, irrespective of trimester and cut-off value. Women scoring below cut-off may be 
reassured that postpartum symptoms of anxiety are unlikely. Adding symptoms of depression 






Due to a paucity of studies on specific symptoms of anxiety during pregnancy and 
in the postpartum period, it remains unclear how many women are affected by these 
symptoms1,2, with estimates ranging from 7% to 33%3-13. Consequences that are associated 
with antenatal anxiety, however, have been studied relatively well. Multiple studies focus 
on unfavourable obstetric outcomes in terms of low birth weight and preterm birth14,15. In 
addition, associations between maternal anxiety/stress and multiple adverse outcomes in 
the child, such as cognitive, behavioral and emotional problems, were found in numerous 
studies10,16-19. Furthermore, antenatal anxiety often precedes postpartum symptoms of 
anxiety or depression3,7,20, or both, as they are known to be highly comorbid3,6.
A commonly used instrument in the identification of symptoms of anxiety is the State 
and Trait Anxiety Inventory (STAI)21, which was validated both in samples of pregnant and 
postpartum women21. Although it is known that having symptoms of anxiety is a risk factor for 
developing an anxiety disorder5, the STAI has not extensively been studied for its accuracy in 
predicting future symptoms of anxiety. As far as we know, only one study has been conducted 
on the predictive accuracy of the STAI in the postpartum period. This study showed that 
women with a high risk of anxiety symptoms in the first two months after delivery (n=522) can 
already be identified in the first days postpartum using the STAI12. Knowing that symptoms of 
anxiety that exist during pregnancy can have serious adverse outcomes for both mother and 
child, and that a psychological therapy such as cognitive behavioral therapy is a treatment 
with a high success rate for symptoms of anxiety, it is essential to identify these symptoms 
as early as possible.
In the current prospective study, we therefore examined to what extent the STAI applied 
during the first, second, and third trimester of pregnancy was accurate in predicting the 
absolute risk of postpartum symptoms of anxiety. In addition, we determined which cut-off 
value yielded the most accurate prediction. In view of the established co-morbidity of anxiety 
and depression, we also investigated whether assessing antenatal depressive symptoms 




The current study was conducted within the prospective Pregnancy, Anxiety and 
Depression (PAD) cohort study in the Netherlands (n=7,275), which included women in their 
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first trimester between May 2010 and September 2014, and aims to investigate antenatal 
and postpartum symptoms of and risk factors for anxiety or depression13. Midwives and 
gynaecologists of participating obstetric care centres (n=116) invited all visiting pregnant 
women to participate in the study. Due to logistic reasons, we are unable to determine how 
many women have actually been invited and, of these, how many agreed to participate. 
The number of participants was however considerably lower than we expected based on 
the number of participating centres. A survey among participating midwives showed that 
pressure of time meant that they could not hand out the forms to all visiting women and that 
they did not specifically invite women they suspected to have an increased risk of depressive 
symptoms. Therefore, we do not think that participants and non-participants differed in 
any considerable way with respect to characteristics relevant to the study due to selective 
inviting22. All participants gave written informed consent.
The study population of the current study was formed by 4,856 women who were five 
months postpartum (range four to seven months) at the time of database closure in December 
2014. Of these women, 74.1% (n=3,600) responded by filling out the postpartum follow-up 
questionnaire on anxiety symptoms. Compared to these responders, non-responders were 
younger (difference less than a year, p=0.001), more often multiparous (p=0.001), had a 
lower educational attainment level (p=0.003) and higher scores on anxiety symptoms and 
depressive symptoms at all antenatal measurement waves (p <0.01).
 The medical ethical review board of the University Medical Center Groningen approved 
this study. 
Measures
Symptoms of antenatal anxiety and depression were measured at 12, 23 and 35 weeks of 
gestation. Postpartum symptoms of anxiety were assessed at five months postpartum. 
Anxiety was measured using the Dutch six-item version of the STAI21, which has acceptable 
concurrent validity when compared to the full 20-item form (r=0.92), and a good internal 
consistency (Cronbach’s α=0.82)21. The questionnaire measures state anxiety (‘how do you 
feel at the moment’), and was validated on a sample of pregnant women21. Scores are on 
the original scale from 20 to 80, with scores of ≥42 indicating an increased risk on anxiety21, 
postpartum scores were dichotomized accordingly. 
To measure antenatal depressive symptoms, we used the validated Dutch 10-item 
Edinburgh Postnatal Depression Scale (EPDS)23, which has shown good internal consistency 
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(Cronbach’s α=0.82)23. The scale ranges from 0 to 30. Total scores of 13 or higher indicate an 
increased risk of minor or major depression during pregnancy24,25. 
Multiple imputation of missing data
Complete information for all variables was present for 2,248 women, i.e. 46.3% of 
women who were at least four months postpartum. The percentage of missing data in the 
present study ranged from 7.8 (age at inclusion) to 26.1 (EPDS five months postpartum) for 
the variables of main interest. To avoid potential bias and decreased statistical power26,27, we 
imputed all missing data on item level, using multiple imputation by chained equations under 
the assumption that missing values were missing at random (MAR) or missing completely at 
random (MCAR). For all variables of main interest, we assessed to what extent we could predict 
their values being missing, using logistic regression, in order to substantiate the assumption 
that the missing data mechanism was MAR. Independent variables were all variables that 
were considered potential predictors of missingness of a value27,28, i.e. antenatal symptoms 
of anxiety and depression, age at baseline, parity and maternal educational attainment level. 
The explained variance (Nagelkerke R2) from these analyses ranged from 1.2% to 8.2%, which 
suggests that data are MAR to some extent, and imputation of missing values would likely 
improve the validity of our analyses. Therefore, all of these variables as well as the outcome 
variable, i.e. postpartum symptoms of anxiety, were included in the imputation model. All 
results were pooled using Rubin’s method for multiple imputation inference29. However, the 
possibility that data were missing not at random has to be borne in mind28. We therefore 
performed a complete case analysis to compare the results with the results of the imputed 
dataset as a sensitivity analysis. Multiple data sets (n=5) were generated. 
Statistical analysis
We first calculated the prevalence of symptoms of anxiety (STAI ≥42) and depression 
(EPDS ≥13) at all antenatal measurements, and the prevalence of postpartum symptoms 
of anxiety. Using a paired samples t-test, we tested whether antenatal levels of anxiety 
and depression significantly differed from postpartum levels. Subsequently, descriptive 
statistics were calculated for demographic variables and scores on the antenatal STAI and 
EPDS assessments. These calculations were done for the total sample and according to the 
presence of postpartum symptoms of anxiety. We tested whether mean values differed 




All following analyses were repeated for all three antenatal measurement waves. 
We determined several performance parameters. First, we calculated the odds ratio for the 
association between increased antenatal and postpartum levels of anxiety or depression by 
conducting a logistic regression analysis. We added symptoms of antenatal depression to 
investigate whether this would give a more accurate prediction of postpartum symptoms of 
anxiety. 
Subsequently, we constructed receiver operating characteristic (ROC) curves and 
calculated the area under the ROC-curve (AUC). Next, sensitivity, specificity and predictive 
values were calculated using several cut-off values for the antenatal STAI to define test 
positive. We started with the commonly used cut-off value of ≥42. Based on the results and 
the ROC-curve, we gradually lowered the cut-off value, and repeated all analyses. Measures 
of predictive accuracy were supplied with 95% confidence intervals.
Additionally, test positive was defined as a score exceeding the cut-off of ≥42 on the STAI 
at all three antenatal measurements, to test whether repeating the assessment of anxiety 
symptoms would give a more accurate prediction, compared to having a score above cut-off 
at one of the antenatal measurements. We repeated this analysis using a lower cut-off, i.e. 
≥36 for all antenatal measurement waves.
Based on a previous study conducted by Dennis et al.12, in which the time interval 
between measurements was four to eight weeks, we conducted a sensitivity analysis in which 
we repeated our analyses and calculated the predictive accuracy with the first trimester as 
predictor variable and the third trimester as outcome variable. Lastly, we performed a 
complete case analysis as a sensitivity analysis. 




At baseline, 619 women (12.7%) experienced symptoms of anxiety (≥42), and 177 women 
(3.6%) experienced symptoms of depression (≥13). Prevalence rates of levels of anxiety and 
depression were highest in the second trimester (n=717, 14.8% and n=187, 3.9% respectively). 
Postpartum symptoms were experienced by 621 women (12.8%), i.e. the prior risk. A total of 
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instances. Seventy-six of these women did not experience postpartum symptoms of anxiety 
(47.8%). Of all women experiencing symptoms of either anxiety or depression at baseline 
(n=662, 13.6%), the vast majority experienced specific symptoms of anxiety (n=484, 73.1%), 
compared to a combination of both anxiety and depression (n=135, 20.4%) or specific 
symptoms of depression (n=43, 6.5%). 
In the total sample, mean levels of anxiety and depression were rather stable (table 1), 
and did not significantly differ (p=0.168). In women experiencing symptoms of anxiety in the 
postpartum period, levels did increase significantly between the baseline and postpartum 
measurements (p<0.001). Parity and all scores of antenatal anxiety or depression differed 
significantly between women with and without postpartum symptoms of anxiety (p<0.0001, 
table 1).
Predictive accuracy of STAI
The performance parameters were calculated in all trimesters for several different cut-
offs. Table 2 and 3 only show the results for the respective cut-offs ≥42 and ≥36, as the first 
is the prevailing cut-off, and the latter yielded the most accurate prediction in terms of 
predictive parameters. The odds ratios ranged from 2.86 [95% CI 2.23, 3.67] at the baseline 
measurement with cut-off ≥33 to 5.15 [95% CI 4.21, 6.28] at the third trimester measurement 
with cut-off ≥42. This same trend was observed after adding symptoms of depression to the 
model, with odds ratios ranging from 1.99 [95% CI 1.56, 2.56] at the baseline measurement 
with cut-off ≥33 to 3.96 [95% CI 3.13, 5.03] at the third trimester measurement with cut-off 
≥42. 
For STAI only, the AUC’s were only reasonable in the second and third trimester (0.74 and 
0.73 respectively)30. After adding symptoms of depression to the models, the AUC was below 
0.64 in all trimesters. 
Furthermore, for the STAI with a cut-off value of ≥42 in the first trimester, the sensitivity 
was low with 28.7% [95% CI 25.1, 32.4], as was the positive predictive value (28.8% [95% CI 
25.2, 32.5]). Specificity and negative predictive values however, were high (89.6% [95% CI 
88.6, 90.5] and 89.5% [95% CI 88.6, 90.5] respectively). When we lowered the cut-off to ≥36 
in the first trimester, the sensitivity increased to 57.2% [95% CI 53.2, 61.1] and the negative 
predictive value to 91.5% [95% CI 90.5, 92.5], especially at the expense of specificity (67.6% 
[95% CI 66.2, 69.0]). 
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Including only women who scored above ≥42 at all three antenatal anxiety measurements 
yielded a sensitivity of 13.0% [95% CI 10.5, 15.9] and a positive predictive value of 49.5% [95% 
CI 41.5, 57.3]. Lowering the cut-off value to ≥36 increased the sensitivity to 36.4% [95% CI 
32.6, 40.3], but decreased the positive predictive value to 32.2% [95% CI 28.7, 35.8].
Sensitivity analyses
In general, the results of the complete case analysis were comparable. Sensitivity and 
positive predictive values appeared to be higher in the complete case analyses, whereas 
specificity and negative predictive values were slightly lower in the complete case analyses.
When using the levels of anxiety in the first trimester as predictor variable and the levels of 
anxiety in the second trimester as outcome variable, we found a sensitivity of 38.4, specificity 
of 91.7 and 44.4 and 89.6 for the positive and negative predictive values respectively. 
Discussion
Main Findings
In this large prospective cohort study, we found that antenatal symptoms of anxiety are 
a strong predictor of symptoms of anxiety in the postpartum period. However, although we 
found reasonable overall discriminatory power in the second and third trimester (AUC 0.74 
and 0.73 respectively), we found a low sensitivity for the prevailing cut-off (i.e. ≥42). Lowering 
the cut-off to ≥36 somewhat improved the predictive performance. For both cut-off values, 
we found exceedingly high negative predictive values; ≥89% for the cut-off value of ≥42 and 
≥91% for the cut-off value of ≥36. This suggests that the prior risk for developing symptoms of 
anxiety in the postpartum period, i.e. 12.8%, could be nearly halved to 6.8% when using the 
cut-off of ≥36 in the second trimester. Although the odds ratios were reasonable after adding 
antenatal symptoms of depression as assessed by the Edinburgh Postnatal Depression Scale 
(EPDS), they were higher without symptoms of depression.
Interpretation
Our findings appear to be contradictive to the findings of Dennis et al.12. They used the 
STAI with a cut-off of >40, which is comparable to ≥42 due to the scale of the six-item version 
of the STAI, and concluded that it can very well be used to identify one-week postpartum 
women who are at risk for symptoms of anxiety seven weeks later (sensitivity 67.5%, 
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specificity 87.1%, positive predictive value 53.0%, negative predictive value 92.5%). This 
difference might be due to the time between measurements; Dennis et al. tested intervals of 
three and seven weeks, whereas the time between the second antenatal and the postpartum 
measurement in our study was approximately 40 weeks. We therefore performed a sensitivity 
analysis between antenatal measurements in the first and second trimester, which equalled 
a time interval of 11 weeks. We then found a more comparable predictive performance 
(sensitivity 38.4%, specificity 91.7%, positive predictive value 44.4%, negative predictive 
value 89.6%), although the sensitivity in our analysis was lower, and the specificity was 
slightly higher. In addition, Dennis et al. stated to accurately classify 84% of all women who 
either did or did not develop symptoms of anxiety. We found the same percentage in our 
sensitivity analyses (83.8%) and a similar percentage between the antenatal and postpartum 
measurements (81.8%). This suggests that the time interval might very well explain the 
contradiction in findings. 
Literature on psychometric properties of the STAI and on postpartum symptoms of 
anxiety as distinct from depression is growing. The consensus is that having antenatal 
symptoms of anxiety or depression is a risk factor for developing postpartum symptoms of 
anxiety or depression. We found high odds ratios in the current study, which substantiate 
these findings. However, the STAI appeared to have limited predictive accuracy for absolute 
risk stratification. Although having antenatal symptoms of anxiety may be a risk factor for 
postpartum symptoms of anxiety as reflected by the high odds ratios, based on antenatal 
STAI measurements, we are not able to accurately identify individual women with a high risk 
of postpartum symptoms of anxiety. 
In line with a previous study, adding symptoms of depression based on the EPDS did 
not increase the prediction of postpartum symptoms of anxiety7. The authors explain their 
finding by the low prevalence rate of depressive disorders (9%) compared to anxiety (33%). 
In the current study, we found that the prevalence of symptoms of depression (range 8.0%-
10.4%) was considerably lower compared to rates of anxiety symptoms (range 11.8%-13.4%), 
which might indicate that depression is not as comorbid in women with anxiety as anxiety is 
in women with depression7,31. 
In a previous study22, we found comparable predictive parameters for postpartum 
symptoms of depression as assessed with the EPDS. Based on our findings and the extensive 
literature on risk factors of postpartum symptoms depression, we were then able to suggest 
a strategy on screening options. Unfortunately, this is impossible for postpartum symptoms 
page
79
of anxiety, as studies on risk factors for such symptoms are scarce. Knowing the potential 
negative consequences for mother and child, the risk of anxiety in either pregnancy or the 
postpartum period, as distinct from depression, should be subject to future research. 
Strengths and limitations
A few limitations have to be considered in the current study. First, both the STAI and 
EPDS are self-report questionnaires, and even though both tools are commonly used in the 
identification of current symptoms of anxiety or depression, it is not possible to diagnose a 
disorder based on these questionnaires. Second, selection bias may be introduced, as women 
who are familiar with symptoms of anxiety or depression may be more inclined to participate. 
This would, however, have led to an underestimation of the found effect. In addition, 
prevalence rates for mental health problems are higher in a population with lower educational 
attainment levels20. In our sample, there is a significant difference between respondents and 
non-respondents on this specific characteristic. However, the percentage of women who 
have completed elementary school or lower tracts of secondary school does not considerably 
differ between respondents and non-respondents. Also, we found significant differences 
between respondents and non-respondents on age and antenatal symptoms of anxiety and 
depression. However, the difference in age was less than a year in absolute numbers and the 
mean scores on antenatal STAI and EPDS were below cut-off at all measurement waves for 
both groups. Therefore, we do not think that these differences affected our prevalence rates.
Several strengths have to be taken into account as well. The current study is a large 
prospective cohort (n=4,856) with a high percentage of women filling out the outcome 
measurement (74.1%). Moreover, by our knowledge, this study is the first to test the accuracy 
of the STAI over a considerably long period of time around childbirth, and to include the 
added value of depressive symptoms based on the STAI in predicting postpartum symptoms 
of anxiety.
Conclusion
Regardless of the cut-off value used or the trimester of administration, the overall 
predictive accuracy of the STAI appears to be limited, although we found a reasonable 
discriminatory power and an exceedingly high negative predictive value. In addition, 
although lowering the cut-off yielded a reasonable sensitivity and specificity, the positive 
predictive value was very low (24.3%). We think the STAI is therefore not suitable for absolute 
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risk stratification in individual women. However, pregnant women scoring below cut-off 
can be reassured that it is very unlikely that they will develop symptoms of anxiety in the 
postpartum period. While the potential adverse outcomes in physical and psychological 
health of both mother and child are relatively well known, future research should focus on 
the improvement of identifying the risk of antenatal and postpartum symptoms of anxiety 
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There is ample evidence from observational prospective studies that maternal 
depression or anxiety during pregnancy is a risk factor for adverse psychosocial outcomes 
in the offspring. However, to date no previous study has demonstrated that treatment of 
depressive or anxious symptoms in pregnancy actually could prevent psychosocial problems 
in children. Preventing psychosocial problems in children will eventually bring down the 
huge public health burden of mental disease. The main objective of this study is to assess 
the effects of cognitive behavioural therapy in pregnant women with symptoms of anxiety 
or depression on the child’s development as well as behavioural and emotional problems. 
In addition, we aim to study its effects on the child’s development, maternal mental health, 
and neonatal outcomes, as well as the cost-effectiveness of cognitive behavioural therapy 
relative to usual care.
Design
We will include 300 women with at least moderate levels of anxiety or depression 
at the end of the first trimester of pregnancy. By including 300 women we will be able to 
demonstrate effect sizes of 0.35 or over on the total problems scale of the child behavioural 
checklist 1.5-5 with alpha 5% and power (1-beta) 80%.
Women in the intervention arm are offered 10-14 individual cognitive behavioural 
therapy sessions, 6-10 sessions during pregnancy and 4-8 sessions after delivery (once a 
week). Women in the control group receive care as usual. 
Primary outcome is behavioural/emotional problems at 1.5 years of age as assessed by the 
total problems scale of the child behaviour checklist 1.5 – 5 years. Secondary outcomes are 
mental, psychomotor and behavioural development of the child at age 18 months according 
to the Bayley scales, maternal anxiety and depression during pregnancy and postpartum, 
and neonatal outcomes such as birth weight, gestational age and Apgar score, health care 






The burden of mental disorders is huge and at least comparable to the burden caused 
by many severe physical diseases. In the WHO Global Burden of Disease project it was 
estimated that 50% of all daily adjusted life years (DALY’s) in the 15-44 years old are due to 
nine psychiatry-related conditions1. Depressive disorders are projected to rank second on a 
list of 15 major diseases in terms of burden of disease in 20302. In addition, a substantial part 
of the costs are caused by new cases, which accounts for 39.2% of the costs at population 
level3. Therefore, prevention of mental disorders is essential.
Maternal anxiety or depression during pregnancy is an important and potentially 
modifiable risk factor for cognitive, behavioural and emotional problems among the 
offspring children4-9. Around 10-20% of all women are suffering from depression or anxiety 
during pregnancy10-13. The magnitude of the effects of maternal anxiety or depression on the 
child’s psychosocial problems is considerable: it is estimated that up to 22% of the variance 
in behavioural problems is linked with prenatal anxiety, stress or depression6. The adverse 
effects seem to be lasting. For example, antenatal anxiety of the mother was related to 
behavioural or emotional problems of 4 year old children, independent of the mother’s 
postnatal depression or anxiety4, and higher anxiety levels of the mothers early in pregnancy 
were related to an increase in ADHD and other externalizing problems in their 8-9 year old 
children14. 
There are several mechanisms through which depression or anxiety during pregnancy 
could have an adverse effect on the offspring. These mechanisms can be divided into direct 
and indirect. A direct mechanism that has been researched for decades is one in which 
depression or anxiety activates the maternal stress system leading to elevated glucocorticoid 
levels, which subsequently influence the development and long-term physiology of the 
foetus’ brain by passing the placenta. This direct mechanism falls under the rubric of “early 
life programming” and has been a popular hypothesis for the explanation of not only brain 
disorders but has been suggested to play a role in cardiovascular disease as well15. Further, 
epigenetic variation has been proposed as a mediating mechanism in linking early life 
exposures to long-term psychological and behavioural outcomes16.
The effect of maternal stress on the developing foetus might also be indirect. Women 
who suffer from antenatal depression have the tendency to take less good care of themselves 
(e.g. neglecting personal hygiene, the occurrence of sleeping problems, disturbed drinking 
and smoking habits, denying prenatal care). These consequences might all influence the 
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development of the foetus17-20. Another indirect way in which depression might influence 
the mental development of the offspring is when the antenatal depression remains after 
delivery and turns into a postnatal depression. In this way, mother-child attachment might be 
endangered, because the mother has a reduced ability to respond to the child. Children from 
depressed mothers have a higher risk of insecure attachment, which in turn is associated with 
cognitive, behavioural and emotional problems1,21-23. In addition, the association between 
antenatal depression and adverse outcomes in the offspring might be indirect because it 
could be explained by a shared genetic predisposition between mother and child. 
Whatever the actual mechanisms involved are, there is presently convincing evidence that 
children whose mothers suffered from anxiety or depression during pregnancy constitute a 
high risk group for behavioural and emotional problems. On population level, substantial total 
mental health gains may be accomplished when depressed or anxious women are adequately 
treated during their pregnancy, even if the effect size of the treatment is relatively small. 
The effectiveness of psychological therapy in the treatment of both depression and 
anxiety has been shown during the past 50 years, especially for cognitive behavioural therapy 
(CBT)24-28. Although guidelines state that medication is an alternative effective treatment, 
the safety of antidepressants during pregnancy remains insecure29. Still, it is too early to 
implement CBT for depressed or anxious women to prevent psychosocial problems in the 
offspring. This is because in the development of such a preventive strategy, demonstration of 
the causality and size of the effect of the reduction of symptoms of depression and anxiety on 
child outcomes is a crucial step, a step that has not been taken to date. This knowledge gap 
will be filled by the results of the present experimental study. 
We are currently performing a randomized controlled trial (RCT) among pregnant women 
with symptoms of depression or anxiety to study the effect of CBT as compared to care as 
usual (CAU) on the offspring’s behavioural and emotional problems. In the CBT arm, we expect 
more beneficial neonatal outcomes, in particular higher birth weight and less prematurity, 
which are risk factors for adverse cognitive and behavioural outcomes themselves8. We also 
anticipate reduced smoking and less drinking, with many physical and mental health benefits 
for the child as a result20. Since prenatal depression has shown to be related to postnatal 
depression, we hypothesize that our intervention will also counter postnatal depression, 
which in turn will benefit the mother – child attachment30. 
Finally, but not unimportantly, the reduction of symptoms of anxiety or depression 
during pregnancy and the early postnatal period is valuable in itself. CBT may further provide 
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for a safer approach to reducing symptoms in pregnancy than antidepressant medication29. 
To date, no such study has been performed as far as we are aware of. 
Design
Objective
The aim of the present study is to examine the effect of CBT in women with at least 
moderate symptoms of anxiety and/or depression at the end of the first trimester of 
pregnancy, on the extent of total behavioural and emotional problems in their children at 1.5 
years of age, as compared with CAU.
Setting
The source population consists of all pregnant women in the Netherlands in the first 
trimester of their pregnancy. Women are recruited in primary, secondary and tertiary 
obstetric care. Women are screened for anxiety and depression symptoms at the end of 
the first trimester of pregnancy. Women with at least moderate symptoms of anxiety and/
or depression are either randomized to the intervention group in which they receive 10-14 
sessions of CBT, or to the control group in which they receive care as usual. Figure 1 shows 
the detailed design of the study. 
Study outcome measures
The primary outcome in this project is the total emotional and behavioural problems 
score of the child according to the Child Behaviour Check List 1.5 – 5 (CBCL 1.5-5) at 18 
months of age. Secondary outcomes are the child’s mental and psychomotor development 
at 18 months of age, the change in depressive and anxious symptoms in the mother, obstetric 
variables such as birth weight, gestational age and Apgar score, the socio-demographic and 
lifestyle factors, such as alcohol use, smoking and education, and cost-effectiveness of the 
therapy.
Sample size
Studies on the prevention of mental disorders tend to suffer from problems of insufficient 
statistical power31. In the current study we aimed to get around this problem by using a 




We decided that effect sizes of 0.35 (midpoint of small – medium effect size) or over on the 
total problems scale of CBCL 1.5-5 are to be detected. With alpha 5% and power (1-beta) 80%, 
we have to include 260 participants in our analyses. To account for some drop out we aim at 
300 women entering the trial. If 50% eventually meets all criteria and gives informed consent, 
600 screen-positives must be identified. The 50% rate is based on studies with psychological 
interventions during pregnancy aimed at reducing the occurrence of postnatal depression30. 
Given the figures in the literature12,32 we can expect amply 10% screen-positives on either 
the anxiety or depression screener. With an estimated 50% comorbidity between anxiety and 
depression this means that approximately 15% are eligible for the randomisation. Therefore, 
4,000 women needed to be screened. Assuming a response rate of 75%33 this implicates that 
5,333 women must be offered screening. To be on the safe side, we aimed at screening 6,000 
women. During the trial it appeared that only 25% rather than 50% of all screen-positive 
women meets all criteria and gives informed consent. Therefore, we adjusted the number 
needed to screen for including 300 women to approximately 12,000. 
Inclusion 
Women in obstetric care in the Netherlands with a significant level of anxiety (6 item 
STAI ≥42) or at least moderate depressive symptoms (EPDS ≥12) in their first trimester were 
invited to participate in the trial. 
Exclusion
Women fulfilling one or more of the following criteria are excluded from participation: 
1. Multiple pregnancy. We decided to exclude women with multiple pregnancy as they have 
a markedly increased obstetric risk; their inclusion would threaten the homogeneity of 
the study population and thereby decrease the sensitivity to detect effects.
2. High suicidal risk according to the suicidality subscale score on the MINI International 
Neuropsychiatric Interview (MINI, defined as a positive response on the question on 
concrete suicide plans)
3. Presently receiving psychotherapy 
4. Substantial physical disease or illegal substance abuse
5. No mastery of the Dutch language
6. Having a psychiatric history on bipolar disorder, psychoses and manic disorder
7. History of in vitro fertilization
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Due to a lower than expected response rate after commencement of the trial we decided 
to also include participants in hospitals to increase the eligible study population, as opposed 
to only including participants in primary care. This implied that we decided to no longer 






























Participating women are asked to fill out questionnaires until their child is 1.5 years. This 
is done at eight time points: the screener at baseline (T0), the additional baseline information 
(T1), and follow-up questionnaires at 24 and 36 weeks of gestation (T3 and T4), at 6 weeks 
postpartum (T5), 6 months postpartum (T6), 12 months postpartum (T7) and 18 months 
postpartum (T8).
At each time point, the levels of anxiety and depression are monitored by the STAI and 
the EPDS. As depicted in table 1, all other questionnaires are filled out once or at several time 
points. For anxiety, we use the Dutch version of the 6-item State Trait Anxiety Inventory (STAI). 
This self-report questionnaire is as valid as the full 20-item version and has frequently been 
used to measure antenatal anxiety32. For the screening on depression we use the Edinburgh 
Postnatal Depression Scale (EPDS), which has 10 items34. This is the most frequently used self 
report depression screener in the postnatal period as well as during pregnancy and has been 
found particularly valid during pregnancy because this scale omits somatic symptoms33. 
The following information is obtained from participants. The exact time of administration 
of the corresponding instrument can be found in figure 2. 
• Life events before pregnancy are assessed at baseline, using the Negative Life Events 
Questionnaire (NLEQ)35. 
• Perceived social support is measured according to the 9-item Social Support 
Questionnaire (SSQ)-short form36.
• General health, socioeconomic position, ethnicity, smoking behavior, alcohol use, 
psychiatric history (whether the participant has had depression and/or anxiety 
symptoms before, whether she was treated for this and whether she is presently in 
treatment for these symptoms is assessed. Socioeconomic position is measured using 
five indicators: family income, educational level (father and mother), and occupational 
level (father and mother). This questionnaire is based on a questionnaire used in the 
Utrecht Health Project (Dutch acronym LRGP: Leidsche Rijn Gezondheids Project, www.
lrgp.nl). General health status will also be taken into account according to the EQ-5D37.
• Personality is assessed using the NEO Five Factor Inventory (NEO-FFI). The NEO-FFI is a 
shortened version of the NEO-PR-I38 and covers the Big Five of personality (neuroticism, 
extraversion, openness, altruism and conscientiousness). These aspects each contain 
6 subscales. The NEO-FFI contains 60 questions, 2 on each subscale. The present 
study will add 4 full subscales to the short version; two subscales of neuroticism, one 
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of extraversion and one of conscientiousness. This is because we expect them to have 
the strongest association with persistence of depression and/or anxiety. The NEO-FFI is 
translated and validated in Dutch39.
• Information on previous pregnancies, family size and composition, pregnancy related 
life events and on reactions on becoming a parent is gathered using questionnaires from 
the ALSPACstudy (www.bristol.ac.uk/alspac). 
• Suicide risk is measured using six screening questions from the MINI International 
Neuropsychiatric Interview40.
• Maternal attachment style is measured according to the ECR41, which has been 
translated and validated for the Netherlands by Conradi et al.42. 
• Health care consumption is assessed based on the TIC-P43. This instrument allows 
reliable recall over the past 6 months44.
• Coping style is assessed using the Utrechtse Coping Lijst, the UCL45. 
• A Dutch version of the Dysfunctional Attitude Scale (DAS) is used to measure cognitions 
and attitudes46.
• Obstetric variables such as gestational age, birth weight, Apgar score, complications 
such as (pre)eclampsia or HELLP, which is obtained from midwifes. Women are asked 
to give consent for this. 
• Finally, we use the SCID-II to screen for a possible clinical depressive or anxiety disorder47. 
The SCID-II is the only questionnaire used that has to be taken in a personal interview.
Besides questionnaires for the mother during her pregnancy and the first 1.5 
years postpartum, there are assessments of the child at 1.5 years of age.  One of the 
assessments concerns the Bayley Scale of Infant Development (BSID-II)48. This is a formal 
neuropsychological tool to assess the developmental level of a child between 1 and 42 
months. It is individually administered by one of the researchers and consists of 3 subscales: 
cognitive development (mental development index), gross and fine motor development and 
the behavioural rating scale. This tool is widely used in both research and clinical settings 
and is considered the best and most applied method for the assessment of the child’s 
development to date49. Importantly, the instrument has shown to be sensitive. In the context 
of our proposal, maternal anxiety in pregnancy explained as much as 11% of the variance in 
the Bayley scores in a study among two year old toddlers by LaPlante et al.50.  
The second assessment is the Child Behaviour Check List 1.5 – 5 (CBCL 1.5-5) including the 
Caregiver-Teacher Report form (C-TRF) and the Language Development Survey (LDS)51.This 
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well established, reliable and valid scale designed for parents and caregivers comprises seven 
syndrome scales: emotionally reactive, anxious depressed, somatic complaints, withdrawn, 
sleep problems, attention problems and aggressive problems. In addition, it contains scales 
for internalizing, externalizing and total problems. Symptom scores may further be related 
to formal DSM-diagnostic criteria. The LDS provides a screen for delays in vocabulary and 
word combinations.
For the assessment of psychopathology in preschool children it is essential to obtain 
information from different sources52. Therefore we decided to include the C-TRF for the 
caregivers of the children other than their parents. Parents are asked to hand these lists to 
the actual caregivers of their children, e.g. grandparents, baby-sitters, kindergarten-coaches, 
et cetera. Relevant in this respect, a review by Skovgaard49 underlined the significance of 
both the developmental aspects (e.g. as measured with the BSID II) and the infant caregiver 
relation in the assessment of children 0-3 years of age. 
The CBCL has been used successfully in several studies, amongst others on externalizing 
problems50. It has been translated and standardized for use in around 60 countries, including 
the Netherlands. The CBCL 1.5-5 is considered a sensitive instrument also deployed in current 
intervention studies54,55.
Also, mother-child interaction are measured by taping them for 15 minutes on video and 
scoring them afterwards on interaction points.
Additional baseline data
Women agreeing to participate are asked to provide additional baseline data at T1, as 
to find in table 1. About half of these questionnaires are sent to the participants in print, the 
other half can be answered online. All follow-up questionnaires are available online. After 
providing baseline data both in print and online, women are telephoned for the Structured 
Clinical Interview for DSM-II Disorders (SCID-II). The SCID-II will allow us to study treatment 
effects additionally according to diagnostic categories rather than symptom levels. 
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Table 1 Assessments per measurement
T0 T1 T2 T3 T4 T5 T6 T7
Depression (EPDS) X X X X X X X X
Anxiety (STAI) X X X X X X X X
Personality NEO-FFI  X  X  X   
Life events before pregnancy (NLEQ)  X       
Life events during pregnancy  X  X  X   
Perceived social support (SSQ)  X       
Coping styles (UCL)  X X X X    
Attitudes (DAS)  X X X X    
Maternal attachment (ECR)  X     X  
Quality of life (EQ-5D)  X X X X X X  
Sociodemographic &  -economic 
factors
 X       
Lifestyle  X  X  X   
Breastfeeding      X   
General health  X       
Health care consumption  X   X X X  
Previous pregnancies  X       
Suicidality (MINI)  X       
Clinical Diagnostic Interview (SCID-II)  X       
Child Behaviour (CBCL)        X




Right after the SCID-II interview, women are randomised 1:1 to either CBT or CAU. 
We will create randomisation lists, stratified for parity and socio-economic position, with 
randomly permuted blocks of random size. Women randomized to the CAU arm are informed 
about being at risk of depression or anxiety disorder by the researchers and are advised to 
contact their GP. A close record is kept of all care provided in the CAU arm.
CBT Intervention
The intervention consists of 10-14 individual sessions: 6-10 sessions during pregnancy and 
4-8 sessions after delivery (once a week). The CBT is conducted by registered psychologists, 
specialized in conducting CBT.
CBT posits that an individual’s biased information processing leads to maladaptive 
feelings and behaviours which can culminate in psychological distress and eventually in 
psychiatric disorders. The main focus of the proposed intervention is targeted on identifying 
and changing dysfunctional cognitions and schemata (attitudes) specifically for pregnant 
depressed and anxious patients. In CBT, the Socratic dialog is used aiming to change these 
dysfunctional cognitions and attitudes permanently. CBT may therefore result in long term 
protection against psychosocial problems. It is therefore not surprising that cognitive therapy 
during the acute phase of depression also appears to be effective in reducing subsequent 
recurrence rates28.
The first session will focus on the rationale CBT, i.e. the influence of (irrational or 
dysfunctional) cognitions and attitudes on feelings and behaviours. Additionally, goal 
setting is initiated. These therapy goals are unique for each patient. The subsequent sessions 
are targeted at identifying and amending irrational cognitions and attitudes related to 
pregnancy, delivery, concerns about the (unborn) child and the future family situation. Each 
session will address specific pregnancy-related cognitions. Additionally, patients are taught 
how dysfunctional cognitions and attitudes affect adversely feelings and behaviours. 
These dysfunctional cognitions and attitudes are challenged and replaced by functional 
cognitions and attitudes. After each session, patients are given home work. For example, 
patients are asked to register negative experiences, and accompanying cognitions, feelings 





If necessary, skewed continuous variables will be transformed to normality prior to the 
analyses. The primary outcome, i.e. the CBCL scores at month 18, will be compared between 
the treatment arms using the unpaired t-test. This test will also be used for detecting 
differences in the Bayley scores by month 18 and the obstetric variables measured at birth. 
The latter group of variables will be tested using the Chi2 test if categorical. Differences in 
attachment style at month 12 will be analyzed using analysis of covariance with the baseline 
variable as a covariate. Continuous outcomes that were measured more than twice (e.g. 
EPDS and STAI) will be analyzed as dependent variables using linear mixed models for fixed 
and random effects. These models are superior for the analysis of longitudinally correlated 
data and can optimally deal with missing values56. A mixed model ascribes a unique intercept 
and slope estimate to each individual, while making use of information across individuals for 
predicting these quantities. In these analyses, a treatment*time variable indicating the effect 
of the intervention will be included as an independent variable. If despite randomisation 
important baseline differences exist in prognostically important variables such as the extent 
of social support or history of life events, they will be adjusted for. Additional analyses will 
be conducted to demonstrate mediation of the effect of CBT on the child’s outcomes by 
maternal symptom level, alcohol or nicotine consumption in pregnancy, medication use or 
neonatal outcomes.
The analyses will primarily be carried out according to the intention-to-treat (ITT) principle, 
i.e. the participants will be analyzed according to their randomized allocation, regardless of 
the actual CBT undergone, or time in study after baseline. Aside from the optimal validity of 
ITT analyses, they quantify the effects on the outcome measures that would be obtained in 
practice. The magnitude of the effect measured in an ITT analysis incorporates the effects 
caused by non-adherence to CBT, behavioural changes, et cetera. Secondary analyses will be 
of the ‘per protocol’ type meaning that they will be restricted to those women that had all of 
the CBT sessions.
Considering specific target populations, there is evidence that the socio-economically 
deprived may have more benefit from treatment of depression during pregnancy18. Therefore, 
subgroup analyses will be undertaken according to socio-economic position. Subgroup 
analyses will also be undertaken according to parity. 
Differences in effect of CBT between subgroups will be statistically evaluated by testing 





An economic evaluation will be conducted alongside the trial to assess the cost-
effectiveness of CBT compared to care as usual in the current study population. Information 
on costs and health outcomes will be prospectively collected during 24 months (starting at 
baseline until 18 months after birth) for both mother and child. Two complementary economic 
analyses will be conducted. The primary outcome measure of the planned cost-effectiveness 
analysis is the total emotional and behavioural problems score of the child according to the 
CBCL at 18 months of age.
In the additionally planned cost-utility analysis, QALYs (Quality Adjusted Life Years) 
will be used as the primary outcome measure. The study will be performed from a societal 
perspective. Medical costs that will be assessed include costs related to CBT, contacts 
with healthcare professionals, and medication use. Outside the healthcare sector, costs 
of informal care and productivity losses will be taken into account. Unit prices will largely 
be based on Dutch standard prices in order to facilitate comparisons with other economic 
evaluations. Cost-effectiveness acceptability curves will be used to inform decision-makers 
on the probability that the studied intervention is cost-effective.
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Symptoms of anxiety and depression during pregnancy and postpartum pose a major 
public health problem, as these symptoms are prevalent and can have serious consequences 
for the mother, her family and the (unborn) baby. Although literature on antenatal and 
postpartum anxiety and depression is extensive, there is a gap in knowledge on the influence 
of specific life events on the development and course of symptoms of anxiety and depression 
in the antenatal and postpartum period, and on accurate antenatal screening methods for 
postpartum symptomatology. As there is no evidence yet that personalized psychosocial 
screening methods and treatment interventions are effective, current screening methods do 
not allow for specific risk factors per woman. This thesis tried add to the existing literature in 
order to bridge this gap in the future. 
We designed a cohort study (n=7,275) and within this cohort we set up a randomized trial 
(n=300). In the cohort, we included pregnant women in the Netherlands in the first trimester 
and followed them until approximately six months postpartum. Women with symptoms of 
anxiety or depression in the first trimester of pregnancy were invited to participate in the 
trial, in which they were randomized into a care as usual or a treatment group that received 
CBT, and were, or will be, visited by a research assistant to have their 1.5 year old child tested 
on its development. 
Main findings
We found that prevalence rates of anxiety and depression are comparable in the 
antenatal and postpartum periods (chapters 2 – 5), which is in line with existing literature. 
We found that women with high levels of anxiety or depression in early pregnancy have an 
increased risk on high levels of anxiety or depression in late pregnancy and in the postpartum 
period (chapters 2 and 3), whereas women with low levels of anxiety or depression in early 
pregnancy are unlikely to experience these symptoms in the postpartum period (chapters 
4 and 5). Additionally, women with symptoms of depression in early pregnancy are more 
likely to experience more symptoms of depression in the postpartum period when they are 
confronted with a life event in the meantime (chapter 3). During pregnancy, specificity of 
life events plays a major role (chapter 2); symptoms of anxiety increase after an event that is 
specifically related to the pregnancy or the unborn child, whereas symptoms of depression 
increase after events that are more general in nature. Based solely on the antenatal levels, it is 
unfortunately not yet possible to accurately predict the individual risk on having postpartum 
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symptoms of anxiety and depression (chapters 4 and 5), though women with no to very 
mild symptoms can be reassured that it is very unlikely that they will develop postpartum 
symptomatology. Therefore, screening in the first trimester may be the first step of a two-
stage screening, subsequently followed by questions on other well-known risk factors for 
postpartum symptomatology (chapter 4). 
Although a considerable number of women experience symptoms of anxiety or 
depression around childbirth, and a brief, reliable, self-report antenatal screening instrument 
to predict the likelihood of minor or major postpartum anxiety or depression would facilitate 
midwives and gynaecologists in daily clinical practice1, the results of this thesis and the state 
of the art in literature raise questions on whether early screening for an increased risk of 
postpartum anxiety or depression should already be recommended This is not a new topic in 
the field. Several systematic reviews are available on the subject, but differ in their findings, 
and RCTs on the efficacy of a screening tool are inconclusive. At the same time, guidelines 
on antenatal maternal care often recommend screening, though they acknowledge that this 
recommendation is not based on a firm body of evidence2,3. 
The general discussion of this thesis therefore applies the criteria as set by Wilson and Jungner4 
and the WHO5 to formulate a recommendation on antenatal screening for postpartum 
anxiety and depression. The criteria can be found in box 1. Some will be discussed separately, 




Box 1 Criteria Wilson & Jungner, and WHO
Condition and test 
1. The condition sought should be an important health problem.
2. The screening programme should respond to a recognized need. (rev)
3. There should be a recognizable latent or early symptomatic stage.
4. The natural history of the condition, including development from latent to declared 
disease, should be adequately understood
5. There should be a suitable test or examination.
6. The test should be acceptable to the population.
Treatment
7. There should be an accepted treatment for patients with recognized disease.
8. There should be an agreed policy on whom to treat as patients.
The programme
9. Case-finding should be a continuing process and not a “once and for all” project. 
10. There should be a defined target population. (rev)
11. The programme should promote equity and access to screening for the entire target 
population. (rev)
12. The objectives of screening should be defined at the outset. (rev)
13. Programme evaluation should be planned from the outset. (rev)
14. The programme should integrate education, testing, clinical services and programme 
management. (rev)
15. The programme should ensure informed choice, confidentiality and respect for 
autonomy. (rev)
16. Facilities for diagnosis and treatment should be available.
17. The cost of case-finding (including diagnosis and treatment of patients diagnosed) 
should be economically balanced in relation to possible expenditure on medical care as 
a whole.
18. There should be scientific evidence of screening programme effectiveness. (rev)
19. There should be quality assurance, with mechanisms to minimize potential risks of 
screening. (rev)




For the purpose of this discussion, the following two criteria are combined; the 
condition sought should be an important health problem (1) and the screening 
programme should respond to a recognized need (2)
Mental health problems are known to have a high burden of disease. In fact, unipolar 
depressive disorder was ranking fourth in the list of leading causes of burden of disease in 
2002, and it has been estimated to be ranking second in 2030, next to HIV/AIDS (rank 1) and 
ischemic heart disease (rank 3)6. Prevalence rates for depression are ranging from 5% to 10% 
and up to 20% for anxiety7,8. Women of reproductive age are known to be highly vulnerable for 
the development of anxiety and depression, as incidence rates are highest amongst women 
18 to 45 years of age9-14. Thus it is no surprise that anxiety and depression occur frequently 
in pregnant or recently pregnant women, and that prevalence rates are comparable15-18. The 
context however accounts for a substantial difference. 
Numerous studies showed that anxiety and depression in the antenatal and postpartum 
periods can have serious consequences for mother and child. Women with mental health 
problems are generally less inclined to take care of themselves and to get prenatal care 
which in turn might influence the development of the fetus19-21. Several studies have 
shown that antenatal anxiety and depression are associated with preterm delivery and low 
birth weight23-25, as well as adverse cognitive, behavioral, and motor development in the 
child25,26-30. Anxiety or depression in the postpartum period can result in insecure mother-child 
attachment, which in turn can result in emotional and behavioral problems in the child and 
subsequently in psychopathology in adults10,31,32. Additionally, mental illnesses are costly to 
the society. It has been estimated that in 2003, major depression has cost the Netherlands 
€1.8 billion33. This includes costs for diagnosis and treatment, but also productivity loss.   
This all has been the starting point for the PROMISES trial in 2009: the above-mentioned 
observational studies had shown the association between subsyndromal antenatal symptoms 
of anxiety and depression, and adverse somatic and psychological outcomes in the child, but 
the causal mechanism behind this had at that time not been found yet. From a public health 
perspective, it is important to unravel this mechanism in order to prevent future incident 
adult cases of psychopathology by decreasing the antenatal anxiety and depression levels in 
women. Although this may not have a high impact on the individual level, it may result in a 
reduced burden of psychiatric disease on the population level. 
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Given the high number of women who will experience symptoms of anxiety or depression 
in the antenatal or postpartum period, the burden it holds and the consequences it can have 
for herself, her baby, her family and society, anxiety and depression around childbirth should 
be considered important health problems.
Two criteria are combined; there should be a recognizable latent or early 
symptomatic stage (3), and the natural history of the condition, including 
development from latent to declared disease, should be adequately understood 
(4)
One way to consider depression is as a continuum, with no symptoms on one end and 
a major depression on the other end34,35. A subclinical depression, i.e. having depressive 
feelings but meeting less than five of the nine criteria or not meeting either one of the two 
core symptoms, can be found somewhere in between. It could develop into a depressive 
disorder, and although a subclinical stage almost always precedes a major depression, it is 
not necessarily an early symptomatic stage36. However, symptoms of depression are not 
exclusive for a depression; loss of interest, sleeping problems, change in dietary patterns 
or loss of libido can occur without being a symptom of depression. In the antenatal and 
postpartum period it may be more complex, as these symptoms can also relate to early 
pregnancy or the postpartum period.   
We found that using the prevailing cut-offs for both anxiety and depression levels, 
sensitivity was low. The number of false positives was thus considerable, indicating that a 
substantial number of women with antenatal symptoms above a certain threshold did not 
experience symptoms above cut-off in the postpartum period. The percentage of false 
positives on the EPDS ranged up to 74%, and up to 70% on the STAI. Another finding of the 
thesis is that specific categories of life events during pregnancy are associated with increased 
levels of anxiety and depression in late pregnancy and the postpartum period. Although this 
may not be a sufficient cause, experiencing life events do add to the occurrence or persistence 
of anxiety and depression. A two-stage screening integrating both findings may be helpful. 
The first stage would be current antenatal symptomatology, followed by a more elaborate 
assessment of established risk factors. These include specific types of life events, social 
support or childhood trauma.  Previous symptomatology and mental disorders may be the 
strongest predictor; a question on previous mental illness should thus certainly be included in 
the second step. Such a stepwise approach has been suggested previously for depression37,38.
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Concluding, it can be difficult to recognize an early stage of depression, especially in the 
antenatal and postpartum period. And though an accurate tool for a reliable prediction on 
who will develop postpartum anxiety or depression symptoms is not yet developed, there 
may be possibilities in a two-stage screening, including a 10-item self-report screening in the 
first step, followed by assessing other risk factors.
Two criteria are combined; there should be a suitable test or examination (5), 
and the test should be acceptable to the population (6)
Current symptoms of anxiety or depression in the antenatal or postpartum period can 
be identified using the 6-item State and Trait Anxiety Inventory (STAI)39 and the 10-item 
Edinburgh Postnatal Depression Scale (EPDS)40, respectively. Both questionnaires are self-
report, are widely used to identify current symptomatology, and have shown to have good 
validity in samples of pregnant and postpartum women39 (i.e. the ability to separate women 
with anxiety or depression from those without). However, for both the STAI and the EPDS, 
the number of true positives is low, indicating that the tests do not allow for risk estimation 
for future symptoms based on current symptomatology. 
Due to the limited questions of the STAI and EPDS, and therefore the limited investment 
of time, both tests are acceptable to the women answering the questions, but are not 
sufficiently accurate and therefore not suitable in the antenatal detection of a high risk of 
postpartum symptoms of anxiety or depression. 
Treatment 
There should be an accepted treatment for patients with recognized disease (7)
Moderate to severe depression is commonly treated with either antidepressants, 
psychological therapy or a combination of both2. In pregnancy, women generally prefer 
psychological treatment41, mostly because of the uncertainties about the safety of 
pharmacological therapies for the health of the unborn baby. The U.S. Food and Drug 
Administration system has classified most antidepressants into risk category C, indicating 
adverse fetal effects in animals. Literature on fetal effects of antidepressants in humans is 
inconclusive42,43.   
Several types of psychological therapy exist, e.g. interpersonal therapy, psychoanalysis, 
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Eye Movement Desensitization and Reprocessing (EMDR) and cognitive behavioral therapy 
(CBT), of which most have been extensively studied on its effectiveness in preventing and 
treating anxiety and depression. The efficacy of CBT for preventing and treating anxiety and 
depression is well-established44-46. However, studies on the effectiveness of CBT in depressed 
pregnant women are scarce. A recent systematic review found that CBT is effective in 
prevention and treatment of depression in the antenatal and postpartum period, although 
interventions were most effective when initiated postpartum47. Although this review included 
40 randomized and quasi-randomized trials, only two trials included pregnant women who 
were offered individual CBT in the antenatal and postpartum period. These studies, however, 
were inconclusive in their results48,49. In other words, studies that can prove whether or 
not the general pregnant population with either subsyndromal or clinical levels of anxiety, 
depression or posttraumatic stress can benefit from CBT have yet to be performed. Currently, 
all women in the PROMISES-trial have delivered their babies. The first results on the effect of 
CBT on pregnant women can therefore be expected later this year. 
Whether CBT is an accepted treatment for all pregnant and postpartum women without 
an urge to seek help, needs to be studied further, as 44% of the sample did not have a mental 
disorder, but subsyndromal symptoms. 
Of all eligible women experiencing either symptoms of anxiety or depression or anxiety 
disorders and/or a depressive disorder and/or posttraumatic stress disorder at baseline 
(n=896, 12% of all screened women), 269 (30%) decided to participate. Reasons women gave 
for not participating were mostly practical in nature, e.g. care for other children or difficulties 
combining therapy and work. Another frequently heard reason was about the nature of the 
symptoms. Some women attributed their fatigue and loss of interest to pregnancy. Other 
women acknowledged that they were experiencing these symptoms, many of them had 
been in therapy before, but they did not want to do something about it during pregnancy, as 
they were afraid they would then not be able to enjoy the pregnancy. 
Concluding, although anxiety disorders, depressive disorder and posttraumatic stress 
disorder in general can effectively be treated with psychotherapy such as cognitive behavioral 
therapy, there is mixed evidence for the effect in treating pregnant women. Additionally, a 
considerable number of women who were screened indicate that they do not want to be 
confronted with the issues behind their symptoms in the antenatal period, thus it cannot 
be stated that the treatment that is available is also an accepted treatment by the patient 
population. This should be taken into account when studying the effectiveness of the 
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treatment during pregnancy. 
There should be an agreed policy on whom to treat as patients (8)
Relatively clear-cut criteria are available for the diagnosis of an anxiety or depressive 
disorder, as well as guidelines on treatment for these patients. Also, efficacy of preventive 
treatment for an anxiety or depressive disorder has been well-established44-46, especially in 
high risk groups in the general population, such as individuals with subclinical symptoms. 
Subclinical symptoms in the antenatal and postpartum period may be difficult to recognize 
due to the similarity to symptoms related to the pregnancy as mentioned before (criteria 3 
and 4). Also, there is no valid tool available yet that accurately identifies pregnant women at 
risk for developing a postpartum anxiety or depressive disorder. Altogether, this could make 
it more difficult to start the treatment while symptoms are (still) mild.
Additionally, the focus in health care is shifting towards precision or personalized 
medicine. As a depressive disorder can be diagnosed with 227 possible combinations of 
symptoms50, it might provide a good basis for precision treatment. Although this is promising, 
current empirical evidence is lacking on whether personalized treatment based on individual 
symptom profiles is more effective than the current standard evidence based treatment. 
The program
Case-finding should be a continuing process and not a “once and for all” project 
(9)
As pregnant women in the Netherlands who do not attend a midwife or gynecologist are 
exceptional, it is possible to screen pregnant women on their risk for postpartum anxiety or 
depression in the prenatal health care system. A screening program can therefore quite easily 
be implemented as a continuing process. However, even though midwives acknowledge the 
potential risks of antenatal anxiety or depression for mother and child, the slow inclusion 
rates in the PAD-study showed that midwives found it difficult to screen all pregnant women 
at the first consult. Based on the number of new clients per month per participating midwifery 
center, we had estimated to be able to screen 6,000 women in 36 midwifery centers in one 
year. After one year however, we had screened 1,400 women, and the 6,000th women was 
screened almost 3 years after the start, when we had expanded the number of collaborating 
chapter 
7
midwifery centers to 100. We conducted a survey amongst midwives to learn about their 
motivation for collaborating in the PAD- study. We found that they thought the study subject 
was very important, but that their time schedules were so tight that they forgot about the 
screening. This may be a problem when screening for anxiety and depression will become 
part of the protocol.  
Two criteria are combined; there should be a defined target population (10), and 
the programme should promote equity and access to screening for the entire 
target population (11)
An obvious target population to screen in order to prevent postpartum anxiety and 
depression would be pregnant women attending a midwife or gynecologist. However, as 
incidence of anxiety and depression is highest in all women 18-45 years of age, there is reason 
to advocate that pregnancy and childbirth may be a necessary but not a sufficient cause. 
Considering also the potential consequences of antenatal anxiety and depression for mother 
and child, it would therefore be desirable to identify and treat women with an increased risk 
of developing anxiety or depression that could persist into the antenatal and postpartum 
period before pregnancy. Women with a desire for pregnancy are however not as easy to find 
as pregnant women, as they are not as regularly attending health care. Also, although they 
have a desire to become pregnant, they may not actually get pregnant.
Concluding, considering the potential consequences of antenatal and depression for 
mother and child, it is desirable to screen and treat in women with a desire to become 
pregnant. As this would result in other problems such as treating women for a disorder they 
could never experience, a perfectly eligible target population remains undefined. 
Although one of the main objectives of the PAD-study was to screen women in the 
first trimester of pregnancy on symptoms of anxiety and depression, it was not designed 
as a screening program for future symptoms that would be implemented in usual care, but 
as a research program. The criteria were thus implicitly taken into account, and discussed 
together.
The objectives of screening should be defined at the outset (12), programme 
evaluation should be planned from the outset (13), the programme should 
integrate education, testing, clinical services and programme management 
(14), and the programme should ensure informed choice, confidentiality and 
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respect for autonomy (15)
When implementing an antenatal screening program for postpartum anxiety and 
depression in usual care, this will also automatically be taken care of, as health care 
professionals highly value confidentiality and informed choice. The specifics of the provided 
information however should be considered carefully, as informing pregnant women that 
elevated antenatal stress levels is associated with adverse outcomes in the unborn child, may 
actually induce stress. 
Additionally, as screening can be considered an intervention, it is important to evaluate 
the effectiveness of the program, as well as the feasibility for health care professionals that 
have to work with it and women who are screened and maybe treated. In the PAD- and 
PROMISES-studies, we did not plan on evaluating the screening. 
Regarding the informed choice criterion, The PROMISES-study showed that 
approximately 70% of all women with elevated anxiety or depression levels did not want to 
participate in the trial as they felt it was not the right time. Additionally, approximately 10% 
of women randomized into the treatment arm dropped out right after randomization, mainly 
because they thought the treatment would be too burdensome. 
Concluding, it is only ethical to fully inform women of the reasons for screening and the 
follow-up protocol, but most women will presumably not start therapy after being identified 
to present with elevated scores of anxiety or depression. This may be tackled by adding one 
simple question to the screening tool; ‘would you be willing to seek professional help for your 
problems?’.
Two criteria combined; facilities for diagnosis and treatment should be available 
(16), and the cost of case-finding (including diagnosis and treatment of patients 
diagnosed) should be economically balanced in relation to possible expenditure 
on medical care as a whole (17)
Obstetric health care centers and psychologists are usually available nearby every town 
in the Netherlands. Midwives and gynecologists can be trained in the screening program, 
though the actual implementation of the program in their daily routine will be more 
complicated. When scores of antenatal anxiety or depression are elevated, psychologists can 
start treatment. This may be the largest obstacle, as women are not actively seeking for help, 
but are indicated to start therapy. Moreover, in the current Dutch health care system, they 
have to pay at least part of the psychological therapy themselves. 
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Regarding the financial aspects, many women will be treated who would not have 
developed the disease, as we are currently not able to accurately predict an individual risk 
on postpartum anxiety or depression based on their antenatal levels. In fact, based on the 
STAI ≥36 and EPDS ≥5, approximately 80% of all women solely experienced symptoms in the 
antenatal period. 
Concluding, although facilities are physically available, it will be difficult to implement 
and very costly as most antenatal anxiety and depression symptoms did not persist into the 
postpartum period.
There should be scientific evidence of screening programme effectiveness (18)
Guidelines on antenatal maternal care often recommend screening but acknowledge 
this recommendation is not based on a firm body of evidence2,3. A recent systematic review 
showed that literature on the effectiveness of a screening program for antenatal and 
postpartum depression is inconclusive51. Most studies investigated efficacy of the treatment, 
rather than the screening per se. According to the review conducted by Thombs, only one 
study randomized women before screening52, which found that postpartum screening was 
effective in preventing postpartum depression.
Concluding, scientific evidence showing effectiveness of an antenatal screening program 
for the risk of postpartum symptomatology is currently lacking.
Two criteria combined; there should be quality assurance, with mechanisms to 
minimize potential risks of screening (19), and the overall benefits of screening 
should outweigh the harm (20)
As approximately 80% of women who experience antenatal symptoms will not experience 
postpartum symptoms, there is a considerable risk in treating women who would not have 
developed the disorder at all. Moreover, if antenatal stress results in adverse outcomes in 
the child, identifying women with antenatal stress by screening in the first trimester may 
already be too late. The main benefit of screening for current symptomatology by using the 
STAI and EPDS lies in the reassurance of women with no symptoms in the antenatal period, 





Conclusion & Future Directions
Anxiety and depression affect approximately 15% of all women of reproductive age, including 
women in the antenatal and postpartum periods. Mental health problems are known to be 
burdensome for the patients and their families. Having such symptoms in this unique period in 
life may have a larger impact. Several studies suggest that antenatal symptomatology can have 
serious consequences for mother and child. Dutch guidelines for midwives therefore recommend 
to assess personal or family history and to be continuously alert on symptoms of depression. 
International guidelines on antenatal maternal care often recommend psychological screening, 
but they acknowledge that they do not base this recommendation on a firm body of evidence. 
Accordingly, scientific evidence showing effectiveness of an antenatal screening program for the 
risk of postpartum symptomatology is currently lacking. Scientific evidence on treatment following 
identification of a high risk in this particular target population is not conclusive either. 
The current thesis adds that treating all women with an increased risk of postpartum 
symptomatology based solely on antenatal levels would result in treating women of whom a majority 
would not have developed symptoms. Moreover, although the Dutch antenatal health care system 
is organized in such a way that implementing a screening program would not be very complicated, 
midwives and gynecologists have very tight schedules, and pregnant women are generally unwilling 
to be confronted with their symptoms. 
On the other hand, there is consensus in literature on risk factors for onset and persistence of 
anxiety and depression, e.g. previous symptomatology and mental disorders, the experience of a 
major life event, certain personality traits and low social support. Also, several tools are accurate 
in identifying the likelihood of current anxiety or depressive disorders. The thesis at hand found 
that these tools are not fully suitable for risk stratification for postpartum symptomatology. 
Though women with none to very low levels of anxiety or depression can be reassured that it is very 
unlikely that they will develop symptoms in the postpartum period, it is uncertain what course can 
be expected for a woman with at least mild symptoms. Screening on antenatal symptomatology 
may however still be a good first step in a two-stage screening program. The first stage would be 
current antenatal symptomatology and mental disorders and the simple question ‘would you be 
willing to seek professional help for your problems?’, followed by a more elaborate assessment of 
the established risk factors when scoring above a certain threshold, including at least an assessment 
of previous symptomatology or mental disorders.
According to the criteria as set by Wilson and Jungner and the WHO (box 1), there are too 
many uncertainties for a heartfelt ‘yes’ on whether an antenatal screening program for postpartum 
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symptomatology would be beneficial. There are however several leads for future studies, 
starting with the results of the PROMISES-trial on the effect of the CBT on the children. 
Condition and test 
1. The condition sought should be an important health problem.
2. The screening programme should respond to a recognized need. (rev)
3. There should be a recognizable latent or early symptomatic stage.
4. The natural history of the condition, including development from latent to declared 
disease, should be adequately understood
5. There should be a suitable test or examination.
6. The test should be acceptable to the population.
Treatment
7. There should be an accepted treatment for patients with recognized disease.
8. There should be an agreed policy on whom to treat as patients.
The programme
9. Case-finding should be a continuing process and not a “once and for all” project. 
10. There should be a defined target population. (rev)
11. The programme should promote equity and access to screening for the entire target 
population. (rev)
12. The objectives of screening should be defined at the outset. (rev)
13. Programme evaluation should be planned from the outset. (rev)
14. The programme should integrate education, testing, clinical services and programme 
management. (rev)
15. The programme should ensure informed choice, confidentiality and respect for 
autonomy. (rev)
16. Facilities for diagnosis and treatment should be available.
17. The cost of case-finding (including diagnosis and treatment of patients diagnosed) 
should be economically balanced in relation to possible expenditure on medical care 
as a whole.
18. There should be scientific evidence of screening programme effectiveness. (rev)
19. There should be quality assurance, with mechanisms to minimize potential risks of 
screening. (rev)
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Approximately 10-15% of all women experience symptoms of anxiety or depression during 
the antenatal or postpartum period. It has been known that having elevated stress levels in 
the antenatal period is associated with adverse outcomes in the child, but the mechanism 
behind this observation has not been found yet. Amongst the main risk factors for anxiety or 
depression in the antenatal or postpartum period are having a history of previous symptoms, 
traumatic events during childhood, recent major life events and specific personality traits. 
Literature is still inconclusive on the associations with traumatic events specifically during 
pregnancy, delivery or in the immediate postpartum period. Chapters 2 and 3 of this thesis 
focus on the influence of such events on the course of anxiety and depression in the antenatal 
and postpartum period. 
Screening for anxiety and depression during pregnancy is generally recommended by 
guidelines on antenatal and postpartum anxiety or depression, although antenatal screening 
tools that accurately predict an individual risk on symptoms in the postpartum period are not 
available yet. Chapters 4 and 5 of this thesis investigate whether two commonly used tools 
in screening for current symptomatology can be used in predicting later symptomatology. 
Treatment options for symptoms of anxiety or depression can be divided into 
pharmacological and non-pharmacological treatment. During the antenatal and 
breastfeeding period, women generally prefer non-pharmacological treatment, such 
as cognitive behavioral therapy. Outside pregnancy, this therapy has been proven to be 
successful in treating anxiety and depression. Chapter 6 focuses on a randomized controlled 
trial investigating the effect of cognitive behavioral therapy on pregnant women and their 
babies. 
Chapter 2 investigates the association between specific types of life events during 
pregnancy and change in symptoms of antenatal anxiety and depression between the 
first and the third trimester (n=1,603). Life events were divided into pregnancy related 
and non-pregnancy related events. We hypothesized that experiencing an event that was 
related to the pregnancy, such as hearing that there might be something wrong with the 
baby or that the partner does not want the child, would have a larger effect on maternal 
symptomatology than non-pregnancy related events. Both types of events were statistically 
significantly associated with an increase in symptoms ofanxiety and depression. In contrast 
to our hypothesis however, effect sizes for non-pregnancy related events were larger than for 
pregnancy related events: 1.17 versus 0.75 for anxiety, and 1.31 versus 0.59 for depression. We 
subsequently tested whether the type of event would be associated with specific anxiety by 
adjusting for depression levels at the third trimester of pregnancy and vice versa, and found 
that non-pregnancy related events were specifically associated with an increase in symptoms 
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of depression (B0.62, 95%CI 0.37-0.86), whereas pregnancy related events were merely 
associated with increasing symptoms of anxiety (B0.4, 95%CI 0.10-0.58). 
We further investigated associations with and potential moderation by levels of 
neuroticism or extraversion, or the experience of a childhood trauma. Personality traits were 
associated with increasing symptoms of both anxiety and depression, but no moderating 
effects were found. Childhood trauma did neither predict changes in anxiety and depression 
levels, nor did it moderate the associations between life events and symptomatology.
In chapter 3, the transition of symptoms from the antenatal into the postpartum period 
is studied (n=3,842). More specifically, to what extent specific life events during pregnancy or 
delivery contributed to the risk of having symptoms of anxiety or depression at six months 
postpartum when they already experienced symptoms in their first trimester of pregnancy. 
We found that experiencing life events during pregnancy that were related to the pregnancy, 
the mode of delivery or the newborn were found not to be associated with an increase in 
levels of anxiety and depression. This is not different for women with and without antenatal 
anxiety or depression.  
Chapter 4 investigated the predictive accuracy of the ten-item Edinburgh Postnatal 
Depression Scale (EPDS) (n=1,620). This tool is commonly used in identifying symptoms of 
depression in the antenatal and postpartum period. The main objective was to investigate 
whether antenatal scores above cut-off accurately predict postpartum scores above cut-off. 
Although the overall discriminatory power was reasonable in all trimesters (AUC ≥0.74), the 
EPDS was not sufficiently accurate in predicting an individual risk of symptoms of depression 
in the postpartum period. We first tested the prevailing cut-offs, i.e. ≥13 for antenatal scores, 
and ≥10 for postpartum scores and subsequently lowered the cut-off gradually. Lowering the 
antenatal cut-off to ≥5 somewhat improved the prediction, though not sufficiently. Women 
scoring <5 can however be reassured that it is very unlikely that they will experience symptoms 
of depression in the postpartum period, as the negative predictive value was exceedingly 
high (96%). Lastly, we found that the predictive accuracy of a two-item screening including 
only items that are key symptoms in depression was not sufficiently accurate. 
Although using only the antenatal scores of the ten-item EPDS may not be accurate 
in predicting an individual risk, they may be adequate in a two-stage screening of which 
the first step would be the EPDS screening in the first trimester. Women with a score ≥5 
can subsequently be screened more elaborately on other risk factors, such as a history of 
depressive episodes, recent life events and social support. Future studies should focus on 
developing and testing such a screening model. 
In chapter 5, the six-item State and Trait Anxiety Inventory (STAI) was investigated on its 
predictive accuracy (n=4,856). This tool is also commonly used, and validated in samples of 
pregnant and postpartum women. Using the prevailing cut-off (≥42), the odds ratio was >3.49 
in all three trimesters. Adding the antenatal EPDS-scores decreased the odds ratios.
The overall discriminatory power was reasonable (AUC 0.73) in the second and third 
trimesters only. Irrespective of cut-off, the predictive performance was poor; with cut-off 
≥42 in the first trimester, sensitivity and positive predictive value were approximately 30%, 
specificity and negative predictive value were around 90%. Using cut-off ≥36 in the second 
trimester, sensitivity and specificity were both approximately 67%, the positive predictive 
value was 23%, while the negative predictive value increased to 93%. 
As negative predictive values were high at all times, women with low anxiety levels can 
be reassured that it is very unlikely that they will experience symptoms of anxiety in the 
postpartum period. A two-stage screening as proposed in chapter 4 cannot be recommended 
here, as there are still many uncertainties about specific risk factors for antenatal postpartum 
anxiety. Future studies should therefore focus on specific anxiety in the antenatal and 
postpartum period, rather than considering anxiety to be a comorbidity of depression.
Chapter 6 presents the design of a randomized controlled trial (RCT). We included 7,275 
women in the cohort in order to include 300 women with mild to moderate levels of anxiety 
or depression in the trial. Women who are randomized into the intervention arm are offered 
10-14 individual cognitive behavioral therapy (CBT) sessions, of which 6-10 will be received 
during pregnancy. Women in the control group receive care as usual (CAU). After baseline 
screening in the first trimester, there are 7 follow-up measurements. The final measurement 
at 18 months postpartum includes maternal anxiety and depression and testing the child on 
cognitive, psychomotor and behavioral development. Besides anxiety and depression, the 
follow-up questionnaires include the experience of life events, personality traits, lifestyle, 
attitudes, coping style, health care consumption and quality of life. 
The thesis concludes with a general discussion in chapter 7 on whether or not to screen 
on antenatal symptomatology in order to prevent postpartum symptoms. The criteria listed 
by Wilson and Jungner and the WHO are applied. Although it is a recognized health problem 
with a high burden, there are too many uncertainties for a heartfelt ‘yes’ on whether an 





Ongeveer 10-15% van alle vrouwen heeft angst- en/of depressieklachten tijdens de 
zwangerschap of na de bevalling. Verhoogde stress tijdens de zwangerschap hangt vaak 
samen met negatieve uitkomsten van het kind, zoals gedragsproblemen, maar hoe dit 
precies werkt is niet duidelijk. Belangrijke risicofactoren voor angst- en/of depressieklachten 
in deze periode zijn het hebben van een voorgeschiedenis van dergelijke klachten, 
traumatische gebeurtenissen in de kindertijd, recente stressvolle levensgebeurtenissen en 
bepaalde persoonlijkheidskenmerken. Uit de literatuur is niet duidelijk of het verloop van 
angst- en depressieklachten tijdens de zwangerschap en na de bevalling ook beïnvloed wordt 
door traumatische gebeurtenissen die tijdens de zwangerschap, de bevalling of directe na 
de bevalling hebben plaatsgevonden. De hoofdstukken 2 en 3 van dit proefschrift geven 
de resultaten van onderzoek naar de invloed van dergelijke gebeurtenissen op angst- en 
depressieklachten in de zwangerschap en na de bevalling.
Screening op angst- en depressieklachten tijdens de zwangerschap om klachten na de 
bevalling te voorkomen wordt door verschillende internationale richtlijnen aanbevolen. 
Goede vragenlijsten om nauwkeurig vast te stellen welke vrouw een hoog of juist een laag 
risico heeft, zijn echter nog niet beschikbaar. In hoofdstukken 4 en 5 worden de bevindingen 
gepresenteerd van onderzoek naar de voorspellende waarde van twee veelgebruikte 
vragenlijsten. We hebben onderzocht of aanwezige klachten gebruikt kunnen worden voor 
het voorspellen van om toekomstige klachten. 
Behandelopties voor angst- en depressieklachten kunnen grofweg verdeeld worden 
in behandeling met medicijnen of middels een psychologische therapie. Tijdens de 
zwangerschap en de borstvoedingsperiode geven de meeste vrouwen de voorkeur aan een 
psychologische therapie, zoals een cognitieve gedragstherapie. Buiten de zwangerschap 
is deze behandeling bewezen effectief gebleken. Daarom bespreken we in hoofdstuk 6  de 
opzet van een onderzoek waarin het effect van een dergelijke psychologische therapie op 
moeder en kind onderzocht zal worden. 
In hoofdstuk 2 wordt een onderzoek beschreven bij 1.603 zwangere vrouwen naar 
veranderingen in angst- en/of depressieklachten tijdens de zwangerschap en of deze 
veranderingen samenhangen met het meemaken van stressvolle levensgebeurtenissen. 
Deze gebeurtenissen werden onderverdeeld in zwangerschapsgerelateerde gebeurtenissen, 
zoals horen dat er misschien iets niet goed is met het kindje, of ontdekken dat de partner het 
kindje niet wil, en niet- zwangerschapsgerelateerde gebeurtenissen, zoals het overlijden van 
een dierbare, of aan een nieuwe baan beginnen. We verwachtten dat het meemaken van een 
gebeurtenis die wel gerelateerd was aan de zwangerschap een grotere impact op de klachten 
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van de moeder zou hebben dan het meemaken van een niet-zwangerschapsgerelateerde 
gebeurtenis. Beide types gebeurtenissen bleken echter samen te hangen met een toename 
in angst- en depressieklachten. Opvallend was dat niet-zwangerschapsgerelateerde 
gebeurtenissen een groter effect op deze toename hadden dan gebeurtenissen die 
wel aan de zwangerschap gerelateerd waren. We hebben vervolgens onderzocht of er 
tussen vrouwen met alleen angstklachten en vrouwen met alleen depressieklachten 
verschil was in het type gebeurtenissen dat ze hadden meegemaakt. We vonden dat niet-
zwangerschapsgerelateerde gebeurtenissen alleen samenhingen met een toename in 
depressieklachten, en dat zwangerschapsgerelateerde klachten alleen samenhingen met een 
toename in angstklachten. We onderzochten tot slot of het meemaken van een traumatische 
gebeurtenis in de kindertijd of het hebben van bepaalde persoonlijkheidskenmerken, zoals 
hoog-neurotisch of laag-extravert, ook een rol speelde in de verandering van angst- of 
depressieklachten gedurende de zwangerschap. Kindertijdtrauma speelde geen rol. Het 
hebben van specifieke persoonlijkheidskenmerken bleek wel samen te hangen met een 
toename in angst- of depressieklachten. Het was echter niet zo dat vrouwen met deze 
kenmerken die tijdens de zwangerschap bepaalde levensgebeurtenissen meemaakten een 
grotere toename van angst-of depressieklachten hadden dan vrouwen die geen of minder 
levensgebeurtenissen mee hadden gemaakt. 
In hoofdstuk 3 wordt bij 3.842 zwangere vrouwen gekeken of bepaalde stressvolle 
levensgebeurtenissen tijdens de zwangerschap of tijdens de bevalling bijdragen aan de 
verandering van angst- en depressieklachten tussen het eerste trimester van de zwangerschap 
en een half jaar na de bevalling. We vonden dat het meemaken van gebeurtenissen die aan 
de zwangerschap gerelateerd waren, de wijze van bevalling, het te vroeg bevallen van de 
baby of het bevallen van een baby met een laag geboortegewicht geen rol speelden in het 
hebben van klachten een half jaar na de bevalling. Bepaalde gebeurtenissen die plaatsvonden 
tijdens de zwangerschap, zoals ziekte of overlijden van een naaste, hingen wel samen met 
angst- of depressieklachten na de bevalling. Ook onderzochten we of vrouwen die al angst- of 
depressieklachten hadden tijdens het eerste trimester van de zwangerschap extra kwetsbaar 
waren om ook na de bevalling klachten te hebben wanneer ze dergelijke gebeurtenissen 
meemaakten. Dit bleek niet het geval te zijn. 
In hoofdstuk 4 onderzochten we bij 1.620 zwangere vrouwen of we met een vragenlijst, 
de Edinburgh Postnatal Depression Scale (EPDS), kunnen voorspellen welke vrouwen na 
de bevalling depressieklachten zullen hebben. Deze vragenlijst bestaat uit 10 vragen en 
wordt veel gebruikt om aanwezige depressieklachten te identificeren, zowel tijdens de 
zwangerschap als na de bevalling. Een score die hoger is dan een bepaalde waarde betekent 
dat deze vrouw meer depressieklachten heeft dan de gemiddelde zwangere vrouw. We 
noemen een dergelijke waarde een afkapwaarde. In dit hoofdstuk wilden we onderzoeken of 
een verhoogde score in de zwangerschap ook een verhoogde score na de bevalling voorspelt. 
Aanwezige klachten zoals gemeten met de EPDS bleken niet voldoende precies om het risico 
op klachten na de bevalling voor een individuele vrouw te kunnen voorspellen. 
We testten eerst de meest gebruikte afkapwaardes, te weten ≥13 voor scores tijdens 
de zwangerschap en ≥10 voor scores na de bevalling. De afkapwaarde voor de score tijdens 
de zwangerschap lieten we vervolgens geleidelijk dalen. Wanneer we een afkapwaarde 
van ≥5 namen werd het voorspellen wel iets preciezer, maar het bleef niet voldoende. Dat 
betekent dat we een vrouw met een score ≥5 niet met zekerheid kunnen zeggen of ze al dan 
niet klachten zal ervaren na de bevalling. Vrouwen met een score van <5 kunnen echter wel 
gerustgesteld worden dat de kans dat zij een half jaar na de bevalling klachten zullen ervaren 
erg laag is, namelijk 4%. Tot slot onderzochten we of het ook mogelijk zou zijn om de kans op 
klachten na de bevalling te voorspellen op basis van slechts twee vragen. Dit zijn de vragen 
die belangrijk zijn in het stellen van de diagnose depressie, namelijk somberheid en verlies 
van plezier. Dit was niet het geval. 
Ook al is het niet voldoende om alleen de scores in de zwangerschap te gebruiken om 
een individueel risico na de bevalling te voorspellen, het zou wel een eerste stap in een 
uitgebreidere screening kunnen zijn. Vrouwen met een score ≥5 zouden bijvoorbeeld 
gescreend kunnen worden op andere bekende risicofactoren voor postpartum depressie, 
zoals een voorgaande depressie, recente stressvolle levensgebeurtenissen of een klein 
sociaal netwerk. Dit is iets om in toekomstige studies te onderzoeken.
In hoofdstuk 5 hebben we een soortgelijk onderzoek uitgevoerd, maar dan naar 
angstklachten. We hebben dit bij 4.856 zwangere vrouwen gedaan, met de vragenlijst 
State and Trait Anxiety Inventory, de STAI. Deze 6-item vragenlijst wordt veel gebruikt om 
aanwezige angstklachten in de zwangerschap of na de bevalling te identificeren. We vonden 
op groepsniveau een erg sterke samenhang tussen scores boven de standaard afkapwaarde 
≥42 tijdens de zwangerschap en na de bevalling. Deze samenhang werd minder sterk wanneer 
we rekening hielden met depressieklachten tijdens de zwangerschap. Dat betekent dat 
angstklachten na de bevalling vooral samenhangen met angstklachten in de zwangerschap. 
We testten zowel de standaard afkapwaarde als een aantal lagere afkapwaardes. Aanwezige 
klachten zoals gemeten met de STAI bleken niet voldoende precies wanneer we voor 
individuele vrouwen een risico op klachten na de bevalling wilden voorspellen, bij geen enkele 
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afkapwaarde. Wanneer we deze vragenlijst wel zouden gebruiken om iets te zeggen over 
angstklachten na de bevalling, zou een groot deel van de vrouwen te horen krijgen dat ze 
een hoge kans heeft op deze klachten terwijl ze uiteindelijk geen klachten ervaarde. Dat zou 
kunnen betekenen dat je deze vrouwen behandelt, terwijl haar klachten sowieso afgenomen 
zouden hebben. Net als in het voorgaande hoofdstuk kunnen we ook hier vrouwen met een 
lage score wel geruststellen dat de kans dat ze toch klachten ervaart na de zwangerschap erg 
klein is. Maar omdat er nog veel onduidelijk is over welke risicofactoren een rol spelen bij het 
ontwikkelen en blijven bestaan van angstklachten tijdens de zwangerschap en na de bevalling, 
kunnen we hier niet een tweetraps screening aanbevelen zoals bij depressieklachten. 
Toekomstige studies zouden zich daarom eerst moeten focussen op dergelijke risicofactoren. 
Hoofdstuk 6 presenteert de opzet van een onderzoek waarbij zwangere vrouwen met 
bovengemiddelde klachten in het eerste trimester willekeurig worden ingedeeld in een groep 
waarin ze psychologische therapie krijgen, of een groep waarin ze deze therapie niet krijgen. 
We wilden 300 vrouwen laten deelnemen.  De deelneemsters werden willekeurig verdeeld 
in twee groepen; de helft ontving 10-14 individuele sessies cognitieve gedragstherapie, de 
andere helft standaardzorg. Na de eerste screening kregen deze vrouwen nog zeven keer 
het verzoek een aantal vragenlijsten in te vullen. Hierin worden vragen gesteld over het 
meemaken van stressvolle levensgebeurtenissen, persoonlijkheidskenmerken, leefstijl, hoe 
ze met tegenslagen omgaan, van welke zorg ze gebruik maken en hoe de kwaliteit van leven 
ervaren wordt. Het laatste verzoek ontvangen ze anderhalf jaar na de bevalling, waarbij naast 
de angst- en depressievragen ook het kindje thuis getest wordt op zijn of haar ontwikkeling, 
zoals motorische en mentale ontwikkeling. 
 
Het proefschrift sluit af met een algemene discussie in hoofdstuk 7. Hierin wordt besproken 
of het zin heeft om tijdens de zwangerschap te screenen op angst- en depressieklachten om 
dergelijke klachten na de bevalling te voorkomen. Criteria die door Wilson, Jungner en de 
Wereldgezondheidsorganisatie zijn opgesteld worden hiervoor als richtlijn gebruikt. 
Angst- en depressieklachten in de zwangerschap en na de bevalling zijn een erkend 
gezondheidsprobleem, en de vrouw en haar omgeving ervaren hierdoor een grote last. Er zijn 
echter te veel onzekerheden over de werkelijke voordelen van screening en behandeling van 
deze groep vrouwen, om hartgrondig ‘ja’ te kunnen antwoorden op de vraag of alle vrouwen 




Zo ongeveer een jaar geleden zat ik rond middernacht in een dichte mist op de fiets naar 
huis. Ik had een kwartier ervoor het laatste artikel naar de co-auteurs gestuurd en was euforisch 
(en naar later bleek wat naïef): nu kon het eind toch niet ver meer zijn! En ineens overviel het me: 
het einde kwam in zicht. De euforie sloeg om in dikke tranen, van opluchting en ontlading. De 
afgelopen jaren zijn heel leerzaam en waardevol, maar soms ook best zwaar geweest. En nu is 
het klaar. 
De eerste mensen die ik wil bedanken zijn de ruim 7.000 deelneemsters. Moeder worden 
is een levensveranderende gebeurtenis met een enorme impact op jezelf, je partner, je gezin. 
Als je dan in die haast breekbare tijd psychische klachten hebt, heb je een zware tijd in plaats 
van de zo gewilde roze wolk. Met deze vrouwen in mijn achterhoofd heb ik de afgelopen 
jaren dit onderzoek gedaan, in de hoop voor hen een verschil te kunnen maken. Dat zij in 
zo’n bijzondere periode van hun leven tijd hebben vrijgemaakt om ons onderzoek verder te 
helpen, is werkelijk geweldig. 
We hebben in dit onderzoek ook veel te danken aan de verloskundigen van ruim 100 
eerstelijnspraktijken, de research nurses van 7 ziekenhuizen, en ruim 30 psychotherapeuten. 
In hun drukke werkzaamheden vonden ze tijd om vrouwen te informeren over het onderzoek, 
om ze te screenen, of om ze op locatie te behandelen. Zonder hun inzet was dit onderzoek 
niet van de grond gekomen!
Mijn promotoren prof.dr. Claudi Bockting en prof.dr. Ronald Stolk en co-promotor dr. 
Huib Burger hebben alle drie een eigen belangrijke rol gespeeld in het gehele traject. 
Huib, al tijdens het sollicitatiegesprek viel me op dat je nieuwsgierig bent naar mensen 
en de wereld om je heen. We hebben heel wat leuke gesprekken gehad over hoe bepaalde 
dingen nu precies in elkaar zouden zitten. Deze nieuwsgierigheid, en hoe je doordacht je 
gedachten formuleert en de zaken van verschillende kanten belicht, zorgden er tijdens het 
analyseren en schrijven altijd voor dat ik goed bleef nadenken over wat de volgende stap zou 
moeten zijn. Van deze voor een onderzoeker onmisbare eigenschappen heb ik ontzettend 
veel geleerd!
Claudi, jouw kennis van depressie en angst waren een heel belangrijke basis van dit 
onderzoek. Door je klinische werk begrijp je zo goed hoe deze aandoeningen iemands leven 
ontwrichten. Ik vind dit essentieel in de wetenschap – weten voor wie je het doet. Ik heb veel 
bewondering voor de manier waarop je in je werk staat en voor je kritische blik die elk stuk 
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dat ik schreef zoveel sterker maakte.
Ronald, de tijd die je in je overvolle agenda voor me vrijmaakte, de manier waarop je me 
zonder waardeoordeel liet weten hoe je ergens over dacht, en de ruimte die je me gaf om 
zelf te zien hoe het anders (of voornamelijk: korter…) kon; het zijn bepalende lessen geweest. 
Tjitte, je hebt altijd originele ideeën om het onderzoek sneller en soepeler te laten 
verlopen. En waar je nu ook weer zat, co-schappen in Friesland of Zuid-Amerika, je was altijd 
volledig onderdeel van het PROMISES-team, wat ik heel bewonderenswaardig vind.
Chantal, we hebben een tijd een kamer gedeeld, en de gangen op de 4e behangen met 
bloemen, vlinders, en vooral geboortekaartjes. Hoe je  al snel een sociaal leven wist op te 
bouwen in de stad was mooi om te zien. 
Juliëtte, wat hebben we samen een tijd doorgebracht in het begin! Bedenken wie we 
gingen benaderen, en hoe we dat dan het beste konden doen. Ik denk nog vaak terug aan 
die tijd, aan hoe leuk het was. Ik vond onze samenwerking heel fijn, je had altijd precies in 
de gaten hoe het ging met PROMISES, en nog steeds kan je me zo vertellen hoe het met de 
dames én de therapeuten gaat. Dat is zo ontzettend waardevol voor een onderzoek! 
I’d also like to thank several co-authors. Mariëlle van Pampus and Hans Ormel, both of 
you have been closely involved with PROMISES. Thanks for your thorough comments on the 
papers. Jeannette Milgrom, I am very grateful for your contribution to the EPDS-paper. 
A special thanks goes to Roman Kotov for having me over at the Stonybrook University 
in 2011, and to Evelyn Bromet for warmly welcoming me in her house during my stay at 
Stonybrook.  
Er zijn heel veel mensen die hebben geholpen met de praktische kanten van PROMISES, 
allemaal vrouwen opvallend genoeg. Lianne en Corien hebben ons erg veel werk uit handen 
genomen door te zorgen voor de registratie van nieuwe deelneemsters, het versturen 
van vragenlijsten, en het testen van de kindjes. Student-assistentes Sanne en Audrey, en 
stagiaires Annemiek, Heleen, Jacobine, Loes, Marrit, Myrthe, Nynke, Renate, Sanne, Ute.
Daarnaast hebben in de loop van de tijd ook heel wat vrienden en familieleden geholpen 
met het klaarmaken van de uitnodigingspakketten. Mam, tante Willemina, tante Harmina, 
Rianne en Marinka, bij de eerste 6.000 pakketten in 2010 hebben jullie drie weken bij de liften 
op de 4e verdieping bij Epidemiologie gezeten om de beruchte rode dozen te vullen. Dit is 
iets waar ik nog steeds met heel veel plezier aan terug denk, het was een bijzonder belangrijk 
onderdeel van het onderzoek!
Mijn collega’s zijn ook van grote waarde geweest, zowel bij Epidemiologie als later bij 
LifeLines. Bij Epi was het fijn ervaringen uitwisselen over alles wat er bij het promoveren 
komt kijken, en er was altijd wel iemand die me kon helpen als ik ergens vastliep. 
Mijn collega’s van LifeLines hebben me vanaf het begin af aan heel warm ontvangen, en ik 
ben heel erg blij met de ruimte die ik heb gekregen om aan mijn proefschrift door te werken. 
Een aantal collega’s wil ik graag in het bijzonder noemen.
Lieve Sas, de eerste maand van ons kamergenootschap durfden we amper iets tegen 
elkaar te zeggen. Toen we eenmaal die drempel over waren, zijn we niet meer gestopt met 
praten. Ik ben enorm blij met jouw steun tijdens het promotietraject, ook op inhoudelijk vlak, 
maar vooral met de vriendschap die het ons heeft opgeleverd. 
Lieve Salome, ook al kenden we elkaar al van onze Epi-tijd, pas bij LifeLines hebben we 
elkaar echt leren kennen. Je hebt me de vrijheid gegeven om mijn uren bij LifeLines zo in te 
richten dat ik dit proefschrift op een zo goed mogelijke manier af kon maken. Ik zal nooit 
vergeten hoe blij je was dat ik na anderhalve week schrijven weer terug was en zei dat het 
voelde alsof ik drie maanden door de Andes had gereisd. Dank voor alles! 
En natuurlijk mijn lieve paranimf Lilian. Na twee weken in een rommelig hotel in hartje 
Rotterdam in 2011 bleek dat we zoveel meer met elkaar gemeen hadden dan we vooraf 
hadden gedacht. Sindsdien was jij ‘my person’ wanneer er een promotie-berg te beklimmen 
was. De nuchtere manier waarop je de wereld bekijkt is heerlijk relativerend. Ik ben daarom 
ook enorm blij dat jij me straks bijstaat! 
Met name de laatste tijd ging alle vrije tijd op aan werk en gezin. Gelukkig heb ik de liefste 
vriendinnen van de wereld die begrijpen hoe die dingen soms gaan. Jelly en Jacobine, dat het 
nooit een probleem was wanneer ik een afspraak afzegde om te schrijven, heeft me enorm 
gesteund. Ik ben ontzettend blij met onze vriendschappen, met hoe het altijd goed is als we 
elkaar weer zien, hoe we altijd tijd tekort komen en hoe we elkaar met een half woord kunnen 
begrijpen. 
Ooms, tantes, neven en nichten van de Geertsma’s en de Meijers, vanaf het begin af aan 
waren jullie geïnteresseerd in mijn onderzoek. Ik vind het heel bijzonder dat jullie er altijd 
voor me zijn, en dat we het de 23e samen kunnen vieren.  
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Lieve Jos en Nella, Nanda en Antoon, Jules en Merijn, Rosa en Jan, Vera en Bas, en Paul. Jullie 
hebben altijd veel interesse gehad in dit onderzoek, meegedacht over hoe het in elkaar zou kunnen 
zitten, maar ook over alles eromheen. Het is zo ontzettend mooi om te zien hoe Tamar bij jullie altijd 
zoveel meer dan welkom is; we zullen het niet gauw nog eens wagen langs te komen/weg te gaan 
zonder haar...! 
Lieve Marij, het was voor mij altijd al duidelijk dat jij mijn paranimf zou zijn: belangrijke dingen 
kunnen niet zonder jou. We hebben de afgelopen jaren zo vaak gepraat over deze promotie, en je 
hebt me altijd gesteund bij de keus om toch door te zetten. Ik kan alleen maar hopen dat ik hetzelfde 
voor jou kan doen wanneer dat nodig is. 
Sjoerd, jij had zoveel beter dan ik in de gaten hoe een promotie zou gaan zijn. Je hebt het slim 
bekeken. Ik hoop enorm dat je er de 23e weer bent! 
Lieve pap en mam, jullie hebben een onbeschrijfelijk groot aandeel in mijn promotie. Naast hard 
werken was het ook een persoonlijke overwinning, één die jullie altijd gesteund hebben. Het meest 
zichtbare aandeel is natuurlijk jullie bereidheid om op Tamar te passen zodat ik door kon werken, dit 
was ons zowel verbaal (‘is het dan niet handiger dat ze al een dag eerder komt?’) als non-verbaal altijd 
heel duidelijk. De glinstering in jullie ogen als jullie haar zien is onbetaalbaar. 
En natuurlijk onze eigen, groeiende familie. 
Liefste kleine Tamar. Jouw oneindige vrolijkheid maakt het leven zoveel leuker! Je was 
tegelijkertijd de grootste motor achter het afmaken van het boek, als de grootste afleiding die er 
bestaat. Zo aan het eind was jij er ook wel klaar mee en sommeerde je me om na het werken snel 
weer naar huis te komen. Daar wachtte me gelukkig altijd een dikke knuffel, fijner thuiskomen is niet 
denkbaar. Vanaf nu zijn alle vrije uren voor jou! 
Liefste Gui, ik weet niet waar ik moet beginnen met je bedanken. Het is vast niet altijd even 
makkelijk geweest, dat ik avonden doorwerkte of energieloos thuiskwam. Er zit ook zoveel van jouw 
tijd in dit boek, maar je hebt er alles aan gedaan om te zorgen dat het afkwam, zelfs de meest rare 
vragen beantwoorden (‘verplaats je eens in een vrouw zonder kinderwens’). Jouw liefde, aanstekelijke 
optimisme en hitlijsten  maken altijd alles goed. Ik heb enorm veel zin in de toekomst samen!
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